Genetic Predisposition to Disease
Genotype
Polymorphism, Genetic
Alleles
Polymorphism, Single Nucleotide
Pedigree
Germ-Line Mutation
Gene Frequency
Case-Control Studies
Risk Factors
Disease Susceptibility
Genetic Testing
Phenotype
Haplotypes
Genetic Markers
Family Health
Genetic Linkage
Mutation
Neoplastic Syndromes, Hereditary
Gene-Environment Interaction
Pelvimetry
Age of Onset
Genetic Association Studies
Chromosome Mapping
Disease Models, Animal
Genome-Wide Association Study
HLA-DQ Antigens
Twins, Monozygotic
Obesity
Penetrance
Diabetes Mellitus, Type 2
Genetic Loci
Linkage Disequilibrium
European Continental Ancestry Group
Genes, BRCA1
Heterozygote
Microsatellite Repeats
Cohort Studies
HLA-DRB1 Chains
Neoplasms, Multiple Primary
Risk
Environment
Neoplasms
Causality
Asian Continental Ancestry Group
Age Factors
Incidence
Autoimmune Diseases
Polymorphism, Single-Stranded Conformational
Neoplasms, Second Primary
Polymerase Chain Reaction
Odds Ratio
Inheritance Patterns
Risk Assessment
HLA Antigens
Mice, Inbred Strains
Autoimmunity
Pregnancy
Thyroiditis, Autoimmune
Chromosomes, Human, Pair 2
Lod Score
Liver Cirrhosis, Biliary
HLA-DR Antigens
Hypertension
Chromosomes, Human, Pair 6
Body Mass Index
Autoantibodies
Celiac Disease
Crohn Disease
Prevalence
Polymorphism, Restriction Fragment Length
Base Sequence
Siblings
Schizophrenia
Chromosomes, Human, Pair 7
Diabetic Nephropathies
Diabetes Mellitus, Type 1
Twins, Dizygotic
Environmental Exposure
Sex Factors
Crosses, Genetic
Peptidyl-Dipeptidase A
Molecular Sequence Data
Promoter Regions, Genetic
Alcoholism
Life Style
RecQ Helicases
Exons
Chi-Square Distribution
Genome, Human
Species Specificity
Disease Progression
Sjogren's Syndrome
DNA-Binding Proteins
Lupus Erythematosus, Systemic
Chromosome Aberrations
Models, Genetic
Bloom Syndrome
Prospective Studies
Brain
France
Colitis, Ulcerative
African Continental Ancestry Group
Logistic Models
Anxiety
Fanconi Anemia
Inflammation
Li-Fraumeni Syndrome
Inflammatory Bowel Diseases
Colorectal Neoplasms
DNA
Gene Expression Profiling
Mice, Transgenic
Body Weight
Epigenesis, Genetic
Carcinogens
Sequence Analysis, DNA
Immunity, Innate
Ethanol
Proteins
Mice, Knockout
Models, Biological
Aging
Reference Values
Biological Markers
Alcohol Drinking
Signal Transduction
Carrier Proteins
Analysis of Variance
Oligonucleotide Array Sequence Analysis
Homeostasis
Cytokines
Ataxia Telangiectasia
Adipose Tissue
BRCA2 Protein
Prognosis
Cardiovascular Diseases
Questionnaires
DNA Repair
Rothmund-Thomson Syndrome
African Americans
Adenomatous Polyposis Coli
Tumor Necrosis Factor-alpha
Regression Analysis
RNA, Messenger
Colorectal Neoplasms, Hereditary Nonpolyposis
Severity of Illness Index
Retrospective Studies
Insulin Resistance
Gene Expression Regulation
Asthma
Peutz-Jeghers Syndrome
Magnetic Resonance Imaging
Intestinal Mucosa
Gene Expression
Registries
Follow-Up Studies
BRCA1 Protein
Longitudinal Studies
Insulin
Genes, BRCA2
Nijmegen Breakage Syndrome
Fanconi Anemia Complementation Group Proteins
Tumor Suppressor Proteins
Neurofibromatoses
Werner Syndrome
Basal Cell Nevus Syndrome
DNA Helicases
MutS Homolog 2 Protein
Ataxia Telangiectasia Mutated Proteins
Beckwith-Wiedemann Syndrome
HLA-DR Serological Subtypes
Neurofibromatosis 1
Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase. (1/27100)
The two genetically established antimicrobial mechanisms of macrophages are production of reactive oxygen intermediates by phagocyte oxidase (phox) and reactive nitrogen intermediates by inducible nitric oxide synthase (NOS2). Mice doubly deficient in both enzymes (gp91(phox-/-)/NOS2(-/-)) formed massive abscesses containing commensal organisms, mostly enteric bacteria, even when reared under specific pathogen-free conditions with antibiotics. Neither parental strain showed such infections. Thus, phox and NOS2 appear to compensate for each other's deficiency in providing resistance to indigenous bacteria, and no other pathway does so fully. Macrophages from gp91(phox-/-)/NOS2(-/-) mice could not kill virulent Listeria. Their killing of S. typhimurium, E. coli, and attenuated Listeria was markedly diminished but demonstrable, establishing the existence of a mechanism of macrophage antibacterial activity independent of phox and NOS2. (+info)Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. (2/27100)
We have generated mice with a cell type-specific disruption of the Stat3 gene in macrophages and neutrophils. The mutant mice are highly susceptible to endotoxin shock with increased production of inflammatory cytokines such as TNF alpha, IL-1, IFN gamma, and IL-6. Endotoxin-induced production of inflammatory cytokines is augmented because the suppressive effects of IL-10 on inflammatory cytokine production from macrophages and neutrophils are completely abolished. The mice show a polarized immune response toward the Th1 type and develop chronic enterocolitis with age. Taken together, Stat3 plays a critical role in deactivation of macrophages and neutrophils mainly exerted by IL-10. (+info)Constitutional genetic variation at the human aromatase gene (Cyp19) and breast cancer risk. (3/27100)
The activity of the aromatase enzyme, which converts androgens into oestrogens and has a major role in regulating oestrogen levels in the breast, is thought to be a contributing factor in the development of breast cancer. We undertook this study to assess the role of constitutional genetic variation in the human aromatase gene (Cyp19) in the development of this disease. Our genotyping of 348 cases with breast cancer and 145 controls (all Caucasian women) for a published tetranucleotide repeat polymorphism at intron 4 of the Cyp19 gene revealed the presence of six common and two rare alleles. Contingency table analysis revealed a significant difference in allelic distribution between cases and controls (chi2 5df = 13.52, P = 0.019). The allele measuring 171 bp was over-represented in cases; of 14 individuals homozygous for this allele, 13 were cases. These individuals had a higher incidence of cancer in family members and an earlier age at diagnosis than other cases. In sequencing Cyp19's coding exons and regulatory regions, we discovered a perfect association between a silent polymorphism (G-->A at Val80) and the high-risk genotype. Our conclusion is that constitutional genetic variation at the Cyp19 locus is associated with the risk of developing breast cancer, with the 171-bp allele serving as the high-risk allele. (+info)The impact of genetic counselling about breast cancer risk on women's risk perceptions and levels of distress. (4/27100)
Women referred to a familial breast cancer clinic completed questionnaires before and after counselling and at annual follow-up to assess their risk estimate and psychological characteristics. The aims were to determine whether those who attended the clinic overestimated their risk or were highly anxious and whether counselling influenced risk estimates and levels of distress. Women (n = 450) at this clinic were more likely to underestimate (39%) than overestimate (14%) their risk. Mean trait anxiety scores were higher than general population data (t = 4.9, n = 1059, P<0.001) but not significantly different from published data from other screening samples. Overestimators (z = 5.69, P<0.0001) and underestimators (z = -8.01, P<0.0001) reported significantly different risk estimates (i.e. increased accuracy) after counselling, but significant inaccuracies persisted. Over- (n = 12) and underestimators (n = 60) were still inaccurate in their risk estimates by a factor of 2 after counselling. Thirty per cent of the sample scored above the cut-off (5/6) for case identification on a screening measure for psychological distress, the General Health Questionnaire (GHQ). GHQ scores were significantly lower after counselling (t = 3.6, d.f. = 384, P = 0.0004) with no evidence of increasing risk estimate causing increased distress. The risk of distress after counselling was greater for younger women and those who were more distressed at first presentation. The counselling offered was effective in increasing the accuracy of risk perceptions without causing distress to those who initially underestimated their risk. It is worrying that inaccuracies persisted, particularly as the demand for service has since reduced the consultation time offered in this clinic. Further work is needed to evaluate alternative models of service delivery using more sophisticated methods of assessing understanding of risk. (+info)Cancer risk in close relatives of women with early-onset breast cancer--a population-based incidence study. (5/27100)
Inherited susceptibility to breast cancer is associated with an early onset and bilateral disease. The extent of familial risks has not, however, been fully assessed in population-based incidence studies. The purpose of the study was to quantify the risks for cancers of the breast, ovary and other sites of close relatives of women in whom breast cancer was diagnosed at an early age. Records collected between 1943 and 1990 at the Danish Cancer Registry were searched, and 2860 women were found in whom breast cancer was diagnosed before age 40. Population registers and parish records were used to identify 14 973 parents, siblings and offspring of these women. Cancer occurrence through to 31 December 1993 was determined within the Cancer Registry's files and compared with national incidence rates. Women with early-onset breast cancer were at a nearly fourfold increased risk of developing a new cancer later in life (268 observed vs. 68.9 expected). The excess risk was most evident for second cancer of the breast (181 vs. 24.5) and for ovarian cancer (20 vs. 3.3). For mothers and sisters, risks for cancers of the breast and ovary were significantly increased by two- to threefold. Bilateral breast cancer and breast-ovarian cancer were very strong predictors of familial risks, with one in four female relatives predicted to develop breast and/or ovarian cancer by age 75. Mothers had a slightly increased risk of colon cancer, but not endometrial cancer. The risk for breast cancer was also increased among fathers (standardized incidence ratio 2.5; 95% CI 0.5-7.4) and especially brothers (29; 7.7-74), although based on small numbers. The risk for prostatic cancer was unremarkable. In this large population-based survey, the first-degree relatives of women who developed breast cancer before age 40 were prone to ovarian cancer as well as male and female breast cancer, but not other tumours that may share susceptibility genes with breast cancer. (+info)Susceptibility to childhood acute lymphoblastic leukemia: influence of CYP1A1, CYP2D6, GSTM1, and GSTT1 genetic polymorphisms. (6/27100)
Although acute lymphoblastic leukemia (ALL) is the most common childhood cancer, factors governing susceptibility to this disease have not yet been identified. As such, ALL offers a useful opportunity to examine the glutathione S-transferase and cytochrome P450 genes in determining susceptibility to pediatric cancers. Both enzymes are involved in carcinogen metabolism and have been shown to influence the risk a variety of solid tumors in adults. To determine whether these genes played a similar role in childhood leukemogenesis, we compared the allele frequencies of 177 childhood ALL patients and 304 controls for the CYP1A1, CYP2D6, GSTM1, and GSTT1 genes. We chose the French population of Quebec as our study population because of its relative genetic homogeneity. The GSTM1 null and CYP1A1*2A genotypes were both found to be significant predictors of ALL risk (odds ratio [OR] = 1.8). Those possessing both genotypes were at an even greater risk of developing the disease (OR = 3.3). None of the other alleles tested for proved to be significant indicators of ALL risk. Unexpectedly, girls carrying the CYP1A1*4 were significantly underrepresented in the ALL group (OR = 0.2), suggesting that a gender-specific protective role exists for this allele. These results suggest that the risk of ALL may indeed be associated with xenobiotics-metabolism, and thus with environmental exposures. Our findings may also explain, in part, why ALL is more prevalent among males than females. (+info)Cytochrome P450 CYP1B1 determines susceptibility to 7, 12-dimethylbenz[a]anthracene-induced lymphomas. (7/27100)
CYP1B1-null mice, created by targeted gene disruption in embryonic stem cells, were born at the expected frequency from heterozygous matings with no observable phenotype, thus establishing that CYP1B1 is not required for mouse development. CYP1B1 was not detectable in cultured embryonic fibroblast (EF) or in different tissues, such as lung, of the CYP1B1-null mouse treated with the aryl hydrocarbon receptor agonist 2,3,7,8-tetrachlorodibenzo-p-dioxin whereas the equivalent wild-type EF cells express basal and substantial inducible CYP1B1 and lung expresses inducible CYP1B1. CYP1A1 is induced to far higher levels than CYP1B1 in liver, kidney, and lung in wild-type mice and is induced to a similar extent in CYP1B1-null mice. 7,12-dimethylbenz[a]anthracene (DMBA) was toxic in wild-type EFs that express CYP1B1 but not CYP1A1. These cells effectively metabolized DMBA, consistent with CYP1B1 involvement in producing the procarcinogenic 3,4-dihydrodiol as a major metabolite, whereas CYP1B1-null EF showed no significant metabolism and were resistant to DMBA-mediated toxicity. When wild-type mice were administered high levels of DMBA intragastrically, 70% developed highly malignant lymphomas whereas only 7.5% of CYP1B1-null mice had lymphomas. Skin hyperplasia and tumors were also more frequent in wild-type mice. These results establish that CYP1B1, located exclusively at extrahepatic sites, mediates the carcinogenicity of DMBA. Surprisingly, CYP1A1, which has a high rate of DMBA metabolism in vitro, is not sufficient for this carcinogenesis, which demonstrates the importance of extrahepatic P450s in determining susceptibility to chemical carcinogens and validates the search for associations between P450 expression and cancer risk in humans. (+info)Type 2 diabetes: evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs. (8/27100)
We are conducting a genome scan at an average resolution of 10 centimorgans (cM) for type 2 diabetes susceptibility genes in 716 affected sib pairs from 477 Finnish families. To date, our best evidence for linkage is on chromosome 20 with potentially separable peaks located on both the long and short arms. The unweighted multipoint maximum logarithm of odds score (MLS) was 3.08 on 20p (location, chi = 19.5 cM) under an additive model, whereas the weighted MLS was 2.06 on 20q (chi = 57 cM, recurrence risk,lambda(s) = 1. 25, P = 0.009). Weighted logarithm of odds scores of 2.00 (chi = 69.5 cM, P = 0.010) and 1.92 (chi = 18.5 cM, P = 0.013) were also observed. Ordered subset analyses based on sibships with extreme mean values of diabetes-related quantitative traits yielded sets of families who contributed disproportionately to the peaks. Two-hour glucose levels in offspring of diabetic individuals gave a MLS of 2. 12 (P = 0.0018) at 9.5 cM. Evidence from this and other studies suggests at least two diabetes-susceptibility genes on chromosome 20. We have also screened the gene for maturity-onset diabetes of the young 1, hepatic nuclear factor 4-a (HNF-4alpha) in 64 affected sibships with evidence for high chromosomal sharing at its location on chromosome 20q. We found no evidence that sequence changes in this gene accounted for the linkage results we observed. (+info)Explanation: Genetic predisposition to disease is influenced by multiple factors, including the presence of inherited genetic mutations or variations, environmental factors, and lifestyle choices. The likelihood of developing a particular disease can be increased by inherited genetic mutations that affect the functioning of specific genes or biological pathways. For example, inherited mutations in the BRCA1 and BRCA2 genes increase the risk of developing breast and ovarian cancer.
The expression of genetic predisposition to disease can vary widely, and not all individuals with a genetic predisposition will develop the disease. Additionally, many factors can influence the likelihood of developing a particular disease, such as environmental exposures, lifestyle choices, and other health conditions.
Inheritance patterns: Genetic predisposition to disease can be inherited in an autosomal dominant, autosomal recessive, or multifactorial pattern, depending on the specific disease and the genetic mutations involved. Autosomal dominant inheritance means that a single copy of the mutated gene is enough to cause the disease, while autosomal recessive inheritance requires two copies of the mutated gene. Multifactorial inheritance involves multiple genes and environmental factors contributing to the development of the disease.
Examples of diseases with a known genetic predisposition:
1. Huntington's disease: An autosomal dominant disorder caused by an expansion of a CAG repeat in the Huntingtin gene, leading to progressive neurodegeneration and cognitive decline.
2. Cystic fibrosis: An autosomal recessive disorder caused by mutations in the CFTR gene, leading to respiratory and digestive problems.
3. BRCA1/2-related breast and ovarian cancer: An inherited increased risk of developing breast and ovarian cancer due to mutations in the BRCA1 or BRCA2 genes.
4. Sickle cell anemia: An autosomal recessive disorder caused by a point mutation in the HBB gene, leading to defective hemoglobin production and red blood cell sickling.
5. Type 1 diabetes: An autoimmune disease caused by a combination of genetic and environmental factors, including multiple genes in the HLA complex.
Understanding the genetic basis of disease can help with early detection, prevention, and treatment. For example, genetic testing can identify individuals who are at risk for certain diseases, allowing for earlier intervention and preventive measures. Additionally, understanding the genetic basis of a disease can inform the development of targeted therapies and personalized medicine."
There are several types of disease susceptibility, including:
1. Genetic predisposition: This refers to the inherent tendency of an individual to develop a particular disease due to their genetic makeup. For example, some families may have a higher risk of developing certain diseases such as cancer or heart disease due to inherited genetic mutations.
2. Environmental susceptibility: This refers to the increased risk of developing a disease due to exposure to environmental factors such as pollutants, toxins, or infectious agents. For example, someone who lives in an area with high levels of air pollution may be more susceptible to developing respiratory problems.
3. Lifestyle susceptibility: This refers to the increased risk of developing a disease due to unhealthy lifestyle choices such as smoking, lack of exercise, or poor diet. For example, someone who smokes and is overweight may be more susceptible to developing heart disease or lung cancer.
4. Immune system susceptibility: This refers to the increased risk of developing a disease due to an impaired immune system. For example, people with autoimmune disorders such as HIV/AIDS or rheumatoid arthritis may be more susceptible to opportunistic infections.
Understanding disease susceptibility can help healthcare providers identify individuals who are at risk of developing certain diseases and provide preventive measures or early intervention to reduce the risk of disease progression. Additionally, genetic testing can help identify individuals with a high risk of developing certain diseases, allowing for earlier diagnosis and treatment.
In summary, disease susceptibility refers to the predisposition of an individual to develop a particular disease or condition due to various factors such as genetics, environment, lifestyle choices, and immune system function. Understanding disease susceptibility can help healthcare providers identify individuals at risk and provide appropriate preventive measures or early intervention to reduce the risk of disease progression.
The hallmark of HNS is the presence of multiple types of cancer, often at an early age and in multiple organs. The most common types of cancer associated with HNS are breast, ovarian, colon, stomach, pancreatic, brain, and skin cancers.
There are several different types of HNS, each caused by a mutation in a specific gene. These include:
1. Familial Adenomatous Polyposis (FAP): This is the most common type of HNS and is caused by a mutation in the APC gene. It is characterized by hundreds or thousands of adenomatous polyps (small growths) in the colon, which can become malignant over time.
2. Turcot Syndrome: This rare disorder is caused by a mutation in the APC gene and is characterized by the development of numerous polyps in the colon, as well as other physical features such as short stature, intellectual disability, and facial dysmorphism.
3. Hereditary Diffuse Gastric Cancer (HDGC): This syndrome is caused by a mutation in the CDH1 gene and is characterized by the development of diffuse gastric cancer, which is a type of stomach cancer that spreads throughout the stomach.
4. Peutz-Jeghers Syndrome (PJS): This rare disorder is caused by a mutation in the STK11 gene and is characterized by the development of polyps in the gastrointestinal tract, as well as other physical features such as pigmented macules on the skin and mucous membranes.
5. Li-Fraumeni Syndrome (LFS): This rare disorder is caused by a mutation in the TP53 gene and is characterized by an increased risk of developing several types of cancer, including breast, ovarian, and soft tissue sarcomas.
There are several other rare genetic disorders that can increase the risk of developing gastric cancer, including:
1. Hereditary Gastric Precancerous Condition (HGPC): This rare disorder is caused by a mutation in the E-cadherin gene and is characterized by the development of precancerous lesions in the stomach.
2. Familial Adenomatous Polyposis (FAP): This rare disorder is caused by a mutation in the APC gene and is characterized by the development of hundreds or thousands of colon polyps, as well as an increased risk of developing gastric cancer.
3. Turcot Syndrome: This rare disorder is caused by a mutation in the APC gene and is characterized by the development of colon polyps, as well as other physical features such as intellectual disability and facial dysmorphism.
4. MEN1 Syndrome: This rare disorder is caused by a mutation in the MEN1 gene and is characterized by an increased risk of developing multiple endocrine neoplasia, which can include gastric cancer.
5. Cowden Syndrome: This rare disorder is caused by a mutation in the PTEN gene and is characterized by an increased risk of developing various types of cancer, including gastric cancer.
6. Li-Fraumeni Syndrome: This rare disorder is caused by a mutation in the TP53 gene and is characterized by an increased risk of developing various types of cancer, including gastric cancer.
It's important to note that not all individuals with these genetic disorders will develop gastric cancer, and many other factors can contribute to the development of this disease. If you have a family history of gastric cancer or one of these rare genetic disorders, it's important to discuss your risk with a qualified healthcare professional and follow any recommended screening or prevention strategies.
1) They share similarities with humans: Many animal species share similar biological and physiological characteristics with humans, making them useful for studying human diseases. For example, mice and rats are often used to study diseases such as diabetes, heart disease, and cancer because they have similar metabolic and cardiovascular systems to humans.
2) They can be genetically manipulated: Animal disease models can be genetically engineered to develop specific diseases or to model human genetic disorders. This allows researchers to study the progression of the disease and test potential treatments in a controlled environment.
3) They can be used to test drugs and therapies: Before new drugs or therapies are tested in humans, they are often first tested in animal models of disease. This allows researchers to assess the safety and efficacy of the treatment before moving on to human clinical trials.
4) They can provide insights into disease mechanisms: Studying disease models in animals can provide valuable insights into the underlying mechanisms of a particular disease. This information can then be used to develop new treatments or improve existing ones.
5) Reduces the need for human testing: Using animal disease models reduces the need for human testing, which can be time-consuming, expensive, and ethically challenging. However, it is important to note that animal models are not perfect substitutes for human subjects, and results obtained from animal studies may not always translate to humans.
6) They can be used to study infectious diseases: Animal disease models can be used to study infectious diseases such as HIV, TB, and malaria. These models allow researchers to understand how the disease is transmitted, how it progresses, and how it responds to treatment.
7) They can be used to study complex diseases: Animal disease models can be used to study complex diseases such as cancer, diabetes, and heart disease. These models allow researchers to understand the underlying mechanisms of the disease and test potential treatments.
8) They are cost-effective: Animal disease models are often less expensive than human clinical trials, making them a cost-effective way to conduct research.
9) They can be used to study drug delivery: Animal disease models can be used to study drug delivery and pharmacokinetics, which is important for developing new drugs and drug delivery systems.
10) They can be used to study aging: Animal disease models can be used to study the aging process and age-related diseases such as Alzheimer's and Parkinson's. This allows researchers to understand how aging contributes to disease and develop potential treatments.
There are several different types of obesity, including:
1. Central obesity: This type of obesity is characterized by excess fat around the waistline, which can increase the risk of health problems such as type 2 diabetes and cardiovascular disease.
2. Peripheral obesity: This type of obesity is characterized by excess fat in the hips, thighs, and arms.
3. Visceral obesity: This type of obesity is characterized by excess fat around the internal organs in the abdominal cavity.
4. Mixed obesity: This type of obesity is characterized by both central and peripheral obesity.
Obesity can be caused by a variety of factors, including genetics, lack of physical activity, poor diet, sleep deprivation, and certain medications. Treatment for obesity typically involves a combination of lifestyle changes, such as increased physical activity and a healthy diet, and in some cases, medication or surgery may be necessary to achieve weight loss.
Preventing obesity is important for overall health and well-being, and can be achieved through a variety of strategies, including:
1. Eating a healthy, balanced diet that is low in added sugars, saturated fats, and refined carbohydrates.
2. Engaging in regular physical activity, such as walking, jogging, or swimming.
3. Getting enough sleep each night.
4. Managing stress levels through relaxation techniques, such as meditation or deep breathing.
5. Avoiding excessive alcohol consumption and quitting smoking.
6. Monitoring weight and body mass index (BMI) on a regular basis to identify any changes or potential health risks.
7. Seeking professional help from a healthcare provider or registered dietitian for personalized guidance on weight management and healthy lifestyle choices.
Type 2 diabetes can be managed through a combination of diet, exercise, and medication. In some cases, lifestyle changes may be enough to control blood sugar levels, while in other cases, medication or insulin therapy may be necessary. Regular monitoring of blood sugar levels and follow-up with a healthcare provider are important for managing the condition and preventing complications.
Common symptoms of type 2 diabetes include:
* Increased thirst and urination
* Fatigue
* Blurred vision
* Cuts or bruises that are slow to heal
* Tingling or numbness in the hands and feet
* Recurring skin, gum, or bladder infections
If left untreated, type 2 diabetes can lead to a range of complications, including:
* Heart disease and stroke
* Kidney damage and failure
* Nerve damage and pain
* Eye damage and blindness
* Foot damage and amputation
The exact cause of type 2 diabetes is not known, but it is believed to be linked to a combination of genetic and lifestyle factors, such as:
* Obesity and excess body weight
* Lack of physical activity
* Poor diet and nutrition
* Age and family history
* Certain ethnicities (e.g., African American, Hispanic/Latino, Native American)
* History of gestational diabetes or delivering a baby over 9 lbs.
There is no cure for type 2 diabetes, but it can be managed and controlled through a combination of lifestyle changes and medication. With proper treatment and self-care, people with type 2 diabetes can lead long, healthy lives.
1. Twin-to-twin transmission: This refers to the transmission of infectious agents or other conditions from one twin to the other in utero, during delivery, or after birth. Examples include rubella, herpes simplex virus, and group B streptococcus.
2. Monozygotic (identical) twins: These twins develop from a single fertilized egg and share an identical genetic makeup. They are at higher risk of developing certain diseases, such as immune system disorders and some types of cancer, because of their shared genetics.
3. Dizygotic (fraternal) twins: These twins develop from two separate eggs and have a similar but not identical genetic makeup. They are at higher risk of developing diseases that affect multiple family members, such as heart disease and type 2 diabetes.
4. Twin-specific diseases: These are conditions that affect only twins or are more common in twins than in the general population. Examples include Klinefelter syndrome, which affects males with an extra X chromosome, and Turner syndrome, which affects females with a missing X chromosome.
5. Twin-related complications: These are conditions that occur during pregnancy or delivery and are more common in twins than in singletons. Examples include preterm labor, growth restriction, and twin-to-twin transfusion syndrome.
6. Genetic disorders: Twins can inherit genetic mutations from their parents, which can increase their risk of developing certain diseases. Examples include sickle cell anemia, cystic fibrosis, and Huntington's disease.
7. Environmental exposures: Twins may be exposed to similar environmental factors during fetal development, which can increase their risk of developing certain health problems. Examples include maternal smoking during pregnancy, exposure to lead or other toxins, and maternal infections during pregnancy.
8. Social and cultural factors: Twins may face unique social and cultural challenges, such as discrimination, stigma, and social isolation, which can affect their mental health and well-being.
It's important to note that while twins may be at increased risk for certain health problems, many twins are born healthy and lead normal, healthy lives. Regular prenatal care, proper nutrition, and a healthy lifestyle can help reduce the risks of complications during pregnancy and after delivery. Additionally, advances in medical technology and research have improved the detection and treatment of many twin-related health issues.
Multiple primary neoplasms can arise in different organs or tissues throughout the body, such as the breast, colon, prostate, lung, or skin. Each tumor is considered a separate entity, with its own unique characteristics, including size, location, and aggressiveness. Treatment for multiple primary neoplasms typically involves surgery, chemotherapy, radiation therapy, or a combination of these modalities.
The diagnosis of multiple primary neoplasms can be challenging due to the overlapping symptoms and radiological findings between the different tumors. Therefore, it is essential to have a thorough clinical evaluation and diagnostic workup to rule out other possible causes of the symptoms and confirm the presence of multiple primary neoplasms.
Multiple primary neoplasms are more common than previously thought, with an estimated prevalence of 2% to 5% in some populations. The prognosis for patients with multiple primary neoplasms varies depending on the location, size, and aggressiveness of each tumor, as well as the patient's overall health status.
It is important to note that multiple primary neoplasms are not the same as metastatic cancer, in which a single primary tumor spreads to other parts of the body. Multiple primary neoplasms are distinct tumors that arise independently from different primary sites within the body.
Neoplasm refers to an abnormal growth of cells that can be benign (non-cancerous) or malignant (cancerous). Neoplasms can occur in any part of the body and can affect various organs and tissues. The term "neoplasm" is often used interchangeably with "tumor," but while all tumors are neoplasms, not all neoplasms are tumors.
Types of Neoplasms
There are many different types of neoplasms, including:
1. Carcinomas: These are malignant tumors that arise in the epithelial cells lining organs and glands. Examples include breast cancer, lung cancer, and colon cancer.
2. Sarcomas: These are malignant tumors that arise in connective tissue, such as bone, cartilage, and fat. Examples include osteosarcoma (bone cancer) and soft tissue sarcoma.
3. Lymphomas: These are cancers of the immune system, specifically affecting the lymph nodes and other lymphoid tissues. Examples include Hodgkin lymphoma and non-Hodgkin lymphoma.
4. Leukemias: These are cancers of the blood and bone marrow that affect the white blood cells. Examples include acute myeloid leukemia (AML) and chronic lymphocytic leukemia (CLL).
5. Melanomas: These are malignant tumors that arise in the pigment-producing cells called melanocytes. Examples include skin melanoma and eye melanoma.
Causes and Risk Factors of Neoplasms
The exact causes of neoplasms are not fully understood, but there are several known risk factors that can increase the likelihood of developing a neoplasm. These include:
1. Genetic predisposition: Some people may be born with genetic mutations that increase their risk of developing certain types of neoplasms.
2. Environmental factors: Exposure to certain environmental toxins, such as radiation and certain chemicals, can increase the risk of developing a neoplasm.
3. Infection: Some neoplasms are caused by viruses or bacteria. For example, human papillomavirus (HPV) is a common cause of cervical cancer.
4. Lifestyle factors: Factors such as smoking, excessive alcohol consumption, and a poor diet can increase the risk of developing certain types of neoplasms.
5. Family history: A person's risk of developing a neoplasm may be higher if they have a family history of the condition.
Signs and Symptoms of Neoplasms
The signs and symptoms of neoplasms can vary depending on the type of cancer and where it is located in the body. Some common signs and symptoms include:
1. Unusual lumps or swelling
2. Pain
3. Fatigue
4. Weight loss
5. Change in bowel or bladder habits
6. Unexplained bleeding
7. Coughing up blood
8. Hoarseness or a persistent cough
9. Changes in appetite or digestion
10. Skin changes, such as a new mole or a change in the size or color of an existing mole.
Diagnosis and Treatment of Neoplasms
The diagnosis of a neoplasm usually involves a combination of physical examination, imaging tests (such as X-rays, CT scans, or MRI scans), and biopsy. A biopsy involves removing a small sample of tissue from the suspected tumor and examining it under a microscope for cancer cells.
The treatment of neoplasms depends on the type, size, location, and stage of the cancer, as well as the patient's overall health. Some common treatments include:
1. Surgery: Removing the tumor and surrounding tissue can be an effective way to treat many types of cancer.
2. Chemotherapy: Using drugs to kill cancer cells can be effective for some types of cancer, especially if the cancer has spread to other parts of the body.
3. Radiation therapy: Using high-energy radiation to kill cancer cells can be effective for some types of cancer, especially if the cancer is located in a specific area of the body.
4. Immunotherapy: Boosting the body's immune system to fight cancer can be an effective treatment for some types of cancer.
5. Targeted therapy: Using drugs or other substances to target specific molecules on cancer cells can be an effective treatment for some types of cancer.
Prevention of Neoplasms
While it is not always possible to prevent neoplasms, there are several steps that can reduce the risk of developing cancer. These include:
1. Avoiding exposure to known carcinogens (such as tobacco smoke and radiation)
2. Maintaining a healthy diet and lifestyle
3. Getting regular exercise
4. Not smoking or using tobacco products
5. Limiting alcohol consumption
6. Getting vaccinated against certain viruses that are associated with cancer (such as human papillomavirus, or HPV)
7. Participating in screening programs for early detection of cancer (such as mammograms for breast cancer and colonoscopies for colon cancer)
8. Avoiding excessive exposure to sunlight and using protective measures such as sunscreen and hats to prevent skin cancer.
It's important to note that not all cancers can be prevented, and some may be caused by factors that are not yet understood or cannot be controlled. However, by taking these steps, individuals can reduce their risk of developing cancer and improve their overall health and well-being.
Examples of autoimmune diseases include:
1. Rheumatoid arthritis (RA): A condition where the immune system attacks the joints, leading to inflammation, pain, and joint damage.
2. Lupus: A condition where the immune system attacks various body parts, including the skin, joints, and organs.
3. Hashimoto's thyroiditis: A condition where the immune system attacks the thyroid gland, leading to hypothyroidism.
4. Multiple sclerosis (MS): A condition where the immune system attacks the protective covering of nerve fibers in the central nervous system, leading to communication problems between the brain and the rest of the body.
5. Type 1 diabetes: A condition where the immune system attacks the insulin-producing cells in the pancreas, leading to high blood sugar levels.
6. Guillain-Barré syndrome: A condition where the immune system attacks the nerves, leading to muscle weakness and paralysis.
7. Psoriasis: A condition where the immune system attacks the skin, leading to red, scaly patches.
8. Crohn's disease and ulcerative colitis: Conditions where the immune system attacks the digestive tract, leading to inflammation and damage to the gut.
9. Sjögren's syndrome: A condition where the immune system attacks the glands that produce tears and saliva, leading to dry eyes and mouth.
10. Vasculitis: A condition where the immune system attacks the blood vessels, leading to inflammation and damage to the blood vessels.
The symptoms of autoimmune diseases vary depending on the specific disease and the organs or tissues affected. Common symptoms include fatigue, fever, joint pain, skin rashes, and swollen lymph nodes. Treatment for autoimmune diseases typically involves medication to suppress the immune system and reduce inflammation, as well as lifestyle changes such as dietary changes and stress management techniques.
Previous articleNeoplastic Cells
Next articleNephrocalcinosis
There are different types of Breast Neoplasms such as:
1. Fibroadenomas: These are benign tumors that are made up of glandular and fibrous tissues. They are usually small and round, with a smooth surface, and can be moved easily under the skin.
2. Cysts: These are fluid-filled sacs that can develop in both breast tissue and milk ducts. They are usually benign and can disappear on their own or be drained surgically.
3. Ductal Carcinoma In Situ (DCIS): This is a precancerous condition where abnormal cells grow inside the milk ducts. If left untreated, it can progress to invasive breast cancer.
4. Invasive Ductal Carcinoma (IDC): This is the most common type of breast cancer and starts in the milk ducts but grows out of them and invades surrounding tissue.
5. Invasive Lobular Carcinoma (ILC): It originates in the milk-producing glands (lobules) and grows out of them, invading nearby tissue.
Breast Neoplasms can cause various symptoms such as a lump or thickening in the breast or underarm area, skin changes like redness or dimpling, change in size or shape of one or both breasts, discharge from the nipple, and changes in the texture or color of the skin.
Treatment options for Breast Neoplasms may include surgery such as lumpectomy, mastectomy, or breast-conserving surgery, radiation therapy which uses high-energy beams to kill cancer cells, chemotherapy using drugs to kill cancer cells, targeted therapy which uses drugs or other substances to identify and attack cancer cells while minimizing harm to normal cells, hormone therapy, immunotherapy, and clinical trials.
It is important to note that not all Breast Neoplasms are cancerous; some are benign (non-cancerous) tumors that do not spread or grow.
Examples of syndromes include:
1. Down syndrome: A genetic disorder caused by an extra copy of chromosome 21 that affects intellectual and physical development.
2. Turner syndrome: A genetic disorder caused by a missing or partially deleted X chromosome that affects physical growth and development in females.
3. Marfan syndrome: A genetic disorder affecting the body's connective tissue, causing tall stature, long limbs, and cardiovascular problems.
4. Alzheimer's disease: A neurodegenerative disorder characterized by memory loss, confusion, and changes in personality and behavior.
5. Parkinson's disease: A neurological disorder characterized by tremors, rigidity, and difficulty with movement.
6. Klinefelter syndrome: A genetic disorder caused by an extra X chromosome in males, leading to infertility and other physical characteristics.
7. Williams syndrome: A rare genetic disorder caused by a deletion of genetic material on chromosome 7, characterized by cardiovascular problems, developmental delays, and a distinctive facial appearance.
8. Fragile X syndrome: The most common form of inherited intellectual disability, caused by an expansion of a specific gene on the X chromosome.
9. Prader-Willi syndrome: A genetic disorder caused by a defect in the hypothalamus, leading to problems with appetite regulation and obesity.
10. Sjogren's syndrome: An autoimmune disorder that affects the glands that produce tears and saliva, causing dry eyes and mouth.
Syndromes can be diagnosed through a combination of physical examination, medical history, laboratory tests, and imaging studies. Treatment for a syndrome depends on the underlying cause and the specific symptoms and signs presented by the patient.
The condition is often caused by gallstones or other blockages that prevent the normal flow of bile from the liver to the small intestine. Over time, the scarring can lead to the formation of cirrhosis, which is characterized by the replacement of healthy liver tissue with scar tissue.
Symptoms of liver cirrhosis, biliary may include:
* Jaundice (yellowing of the skin and eyes)
* Itching
* Fatigue
* Abdominal pain
* Dark urine
* Pale stools
The diagnosis of liver cirrhosis, biliary is typically made through a combination of physical examination, medical history, and diagnostic tests such as ultrasound, CT scans, and blood tests.
Treatment for liver cirrhosis, biliary depends on the underlying cause of the condition. In some cases, surgery may be necessary to remove gallstones or repair damaged bile ducts. Medications such as antioxidants and anti-inflammatory drugs may also be prescribed to help manage symptoms and slow the progression of the disease. In severe cases, a liver transplant may be necessary.
Prognosis for liver cirrhosis, biliary is generally poor, as the condition can lead to complications such as liver failure, infection, and cancer. However, with early diagnosis and appropriate treatment, it is possible to manage the symptoms and slow the progression of the disease.
There are two types of hypertension:
1. Primary Hypertension: This type of hypertension has no identifiable cause and is also known as essential hypertension. It accounts for about 90% of all cases of hypertension.
2. Secondary Hypertension: This type of hypertension is caused by an underlying medical condition or medication. It accounts for about 10% of all cases of hypertension.
Some common causes of secondary hypertension include:
* Kidney disease
* Adrenal gland disorders
* Hormonal imbalances
* Certain medications
* Sleep apnea
* Cocaine use
There are also several risk factors for hypertension, including:
* Age (the risk increases with age)
* Family history of hypertension
* Obesity
* Lack of exercise
* High sodium intake
* Low potassium intake
* Stress
Hypertension is often asymptomatic, and it can cause damage to the blood vessels and organs over time. Some potential complications of hypertension include:
* Heart disease (e.g., heart attacks, heart failure)
* Stroke
* Kidney disease (e.g., chronic kidney disease, end-stage renal disease)
* Vision loss (e.g., retinopathy)
* Peripheral artery disease
Hypertension is typically diagnosed through blood pressure readings taken over a period of time. Treatment for hypertension may include lifestyle changes (e.g., diet, exercise, stress management), medications, or a combination of both. The goal of treatment is to reduce the risk of complications and improve quality of life.
The primary symptoms of celiac disease include diarrhea, abdominal pain, fatigue, weight loss, and bloating. However, some people may not experience any symptoms at all, but can still develop complications if the disease is left untreated. These complications can include malnutrition, anemia, osteoporosis, and increased risk of other autoimmune disorders.
The exact cause of celiac disease is unknown, but it is believed to be triggered by a combination of genetic and environmental factors. The disease is more common in people with a family history of celiac disease or other autoimmune disorders. Diagnosis is typically made through a combination of blood tests and intestinal biopsy, and treatment involves a strict gluten-free diet.
Dietary management of celiac disease involves avoiding all sources of gluten, including wheat, barley, rye, and some processed foods that may contain hidden sources of these grains. In some cases, nutritional supplements may be necessary to ensure adequate intake of certain vitamins and minerals.
While there is no known cure for celiac disease, adherence to a strict gluten-free diet can effectively manage the condition and prevent long-term complications. With proper management, people with celiac disease can lead normal, healthy lives.
Crohn disease can occur in any part of the GI tract, from the mouth to the anus, but it most commonly affects the ileum (the last portion of the small intestine) and the colon. The inflammation caused by Crohn disease can lead to the formation of scar tissue, which can cause narrowing or blockages in the intestines. This can lead to complications such as bowel obstruction or abscesses.
The exact cause of Crohn disease is not known, but it is believed to be an autoimmune disorder, meaning that the immune system mistakenly attacks healthy tissue in the GI tract. Genetic factors and environmental triggers such as smoking and diet also play a role in the development of the disease.
There is no cure for Crohn disease, but various treatments can help manage symptoms and prevent complications. These may include medications such as anti-inflammatory drugs, immunosuppressants, and biologics, as well as lifestyle changes such as dietary modifications and stress management techniques. In severe cases, surgery may be necessary to remove damaged portions of the GI tract.
Crohn disease can have a significant impact on quality of life, and it is important for individuals with the condition to work closely with their healthcare provider to manage their symptoms and prevent complications. With proper treatment and self-care, many people with Crohn disease are able to lead active and fulfilling lives.
The term "schizophrenia" was first used by the Swiss psychiatrist Eugen Bleuler in 1908 to describe the splitting of mental functions, which he believed was a key feature of the disorder. The word is derived from the Greek words "schizein," meaning "to split," and "phrenos," meaning "mind."
There are several subtypes of schizophrenia, including:
1. Paranoid Schizophrenia: Characterized by delusions of persecution and suspicion, and a tendency to be hostile and defensive.
2. Hallucinatory Schizophrenia: Characterized by hearing voices or seeing things that are not there.
3. Disorganized Schizophrenia: Characterized by disorganized thinking and behavior, and a lack of motivation or interest in activities.
4. Catatonic Schizophrenia: Characterized by immobility, mutism, and other unusual movements or postures.
5. Undifferentiated Schizophrenia: Characterized by a combination of symptoms from the above subtypes.
The exact cause of schizophrenia is still not fully understood, but it is believed to involve a combination of genetic, environmental, and neurochemical factors. It is important to note that schizophrenia is not caused by poor parenting or a person's upbringing.
There are several risk factors for developing schizophrenia, including:
1. Genetics: A person with a family history of schizophrenia is more likely to develop the disorder.
2. Brain chemistry: Imbalances in neurotransmitters such as dopamine and serotonin have been linked to schizophrenia.
3. Prenatal factors: Factors such as maternal malnutrition or exposure to certain viruses during pregnancy may increase the risk of schizophrenia in offspring.
4. Childhood trauma: Traumatic events during childhood, such as abuse or neglect, have been linked to an increased risk of developing schizophrenia.
5. Substance use: Substance use has been linked to an increased risk of developing schizophrenia, particularly cannabis and other psychotic substances.
There is no cure for schizophrenia, but treatment can help manage symptoms and improve quality of life. Treatment options include:
1. Medications: Antipsychotic medications are the primary treatment for schizophrenia. They can help reduce positive symptoms such as hallucinations and delusions, and negative symptoms such as a lack of motivation or interest in activities.
2. Therapy: Cognitive-behavioral therapy (CBT) and other forms of talk therapy can help individuals with schizophrenia manage their symptoms and improve their quality of life.
3. Social support: Support from family, friends, and support groups can be an important part of the treatment plan for individuals with schizophrenia.
4. Self-care: Engaging in activities that bring pleasure and fulfillment, such as hobbies or exercise, can help individuals with schizophrenia improve their overall well-being.
It is important to note that schizophrenia is a complex condition, and treatment should be tailored to the individual's specific needs and circumstances. With appropriate treatment and support, many people with schizophrenia are able to lead fulfilling lives and achieve their goals.
There are several types of diabetic nephropathy, including:
1. Mesangial proliferative glomerulonephritis: This is the most common type of diabetic nephropathy and is characterized by an overgrowth of cells in the mesangium, a part of the glomerulus (the blood-filtering unit of the kidney).
2. Segmental sclerosis: This type of diabetic nephropathy involves the hardening of some parts of the glomeruli, leading to decreased kidney function.
3. Fibrotic glomerulopathy: This is a rare form of diabetic nephropathy that is characterized by the accumulation of fibrotic tissue in the glomeruli.
4. Membranous nephropathy: This type of diabetic nephropathy involves the deposition of immune complexes (antigen-antibody complexes) in the glomeruli, leading to inflammation and damage to the kidneys.
5. Minimal change disease: This is a rare form of diabetic nephropathy that is characterized by minimal changes in the glomeruli, but with significant loss of kidney function.
The symptoms of diabetic nephropathy can be non-specific and may include proteinuria (excess protein in the urine), hematuria (blood in the urine), and decreased kidney function. Diagnosis is typically made through a combination of physical examination, medical history, laboratory tests, and imaging studies such as ultrasound or CT scans.
Treatment for diabetic nephropathy typically involves managing blood sugar levels through lifestyle changes (such as diet and exercise) and medication, as well as controlling high blood pressure and other underlying conditions. In severe cases, dialysis or kidney transplantation may be necessary. Early detection and management of diabetic nephropathy can help slow the progression of the disease and improve outcomes for patients with this condition.
Symptoms of type 1 diabetes can include increased thirst and urination, blurred vision, fatigue, weight loss, and skin infections. If left untreated, type 1 diabetes can lead to serious complications such as kidney damage, nerve damage, and blindness.
Type 1 diabetes is diagnosed through a combination of physical examination, medical history, and laboratory tests such as blood glucose measurements and autoantibody tests. Treatment typically involves insulin therapy, which can be administered via injections or an insulin pump, as well as regular monitoring of blood glucose levels and appropriate lifestyle modifications such as a healthy diet and regular exercise.
There are several types of skin neoplasms, including:
1. Basal cell carcinoma (BCC): This is the most common type of skin cancer, and it usually appears as a small, fleshy bump or a flat, scaly patch. BCC is highly treatable, but if left untreated, it can grow and invade surrounding tissue.
2. Squamous cell carcinoma (SCC): This type of skin cancer is less common than BCC but more aggressive. It typically appears as a firm, flat, or raised bump on sun-exposed areas. SCC can spread to other parts of the body if left untreated.
3. Melanoma: This is the most serious type of skin cancer, accounting for only 1% of all skin neoplasms but responsible for the majority of skin cancer deaths. Melanoma can appear as a new or changing mole, and it's essential to recognize the ABCDE signs (Asymmetry, Border irregularity, Color variation, Diameter >6mm, Evolving size, shape, or color) to detect it early.
4. Sebaceous gland carcinoma: This rare type of skin cancer originates in the oil-producing glands of the skin and can appear as a firm, painless nodule on the forehead, nose, or other oily areas.
5. Merkel cell carcinoma: This is a rare and aggressive skin cancer that typically appears as a firm, shiny bump on the skin. It's more common in older adults and those with a history of sun exposure.
6. Cutaneous lymphoma: This type of cancer affects the immune system and can appear as a rash, nodules, or tumors on the skin.
7. Kaposi sarcoma: This is a rare type of skin cancer that affects people with weakened immune systems, such as those with HIV/AIDS. It typically appears as a flat, red or purple lesion on the skin.
While skin cancers are generally curable when detected early, it's important to be aware of your skin and notice any changes or unusual spots, especially if you have a history of sun exposure or other risk factors. If you suspect anything suspicious, see a dermatologist for an evaluation and potential biopsy. Remember, prevention is key to avoiding the harmful effects of UV radiation and reducing your risk of developing skin cancer.
The Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) defines alcohol use disorder as a maladaptive pattern of alcohol use that leads to clinically significant impairment or distress in at least three of the following areas:
1. Drinking more or for longer than intended.
2. Desire or unsuccessful efforts to cut down or control drinking.
3. Spending a lot of time drinking or recovering from its effects.
4. Craving or strong desire to drink.
5. Drinking interferes with work, school, or home responsibilities.
6. Continuing to drink despite social or personal problems caused by alcohol use.
7. Giving up important activities in order to drink.
8. Drinking in hazardous situations (e.g., while driving).
9. Continued drinking despite physical or psychological problems caused or worsened by alcohol use.
10. Developing tolerance (i.e., needing to drink more to achieve the desired effect).
11. Experiencing withdrawal symptoms when alcohol use is stopped or reduced.
The severity of alcoholism is categorized into three subtypes based on the number of criteria met: mild, moderate, and severe. Treatment for alcoholism typically involves a combination of behavioral interventions (e.g., cognitive-behavioral therapy, motivational interviewing) and medications (e.g., disulfiram, naltrexone, acamprosate) to manage withdrawal symptoms and cravings.
In conclusion, alcoholism is a chronic and often progressive disease characterized by excessive and compulsive consumption of alcohol despite negative consequences to physical and mental health, relationships, and social functioning. The diagnostic criteria for alcoholism include a combination of physiological, behavioral, and subjective symptoms, and treatment typically involves a combination of behavioral interventions and medications to manage withdrawal symptoms and cravings.
Disease progression can be classified into several types based on the pattern of worsening:
1. Chronic progressive disease: In this type, the disease worsens steadily over time, with a gradual increase in symptoms and decline in function. Examples include rheumatoid arthritis, osteoarthritis, and Parkinson's disease.
2. Acute progressive disease: This type of disease worsens rapidly over a short period, often followed by periods of stability. Examples include sepsis, acute myocardial infarction (heart attack), and stroke.
3. Cyclical disease: In this type, the disease follows a cycle of worsening and improvement, with periodic exacerbations and remissions. Examples include multiple sclerosis, lupus, and rheumatoid arthritis.
4. Recurrent disease: This type is characterized by episodes of worsening followed by periods of recovery. Examples include migraine headaches, asthma, and appendicitis.
5. Catastrophic disease: In this type, the disease progresses rapidly and unpredictably, with a poor prognosis. Examples include cancer, AIDS, and organ failure.
Disease progression can be influenced by various factors, including:
1. Genetics: Some diseases are inherited and may have a predetermined course of progression.
2. Lifestyle: Factors such as smoking, lack of exercise, and poor diet can contribute to disease progression.
3. Environmental factors: Exposure to toxins, allergens, and other environmental stressors can influence disease progression.
4. Medical treatment: The effectiveness of medical treatment can impact disease progression, either by slowing or halting the disease process or by causing unintended side effects.
5. Co-morbidities: The presence of multiple diseases or conditions can interact and affect each other's progression.
Understanding the type and factors influencing disease progression is essential for developing effective treatment plans and improving patient outcomes.
Sjögren's syndrome can affect people of all ages, but it most commonly occurs in women between the ages of 40 and 60. The exact cause of the disorder is not known, but it is believed to be an autoimmune response, meaning that the immune system mistakenly attacks the glands as if they were foreign substances.
Symptoms of Sjögren's syndrome can vary in severity and may include:
* Dry mouth (xerostomia)
* Dry eyes (dry eye syndrome)
* Fatigue
* Joint pain
* Swollen lymph nodes
* Rash
* Sores on the skin
* Numbness or tingling in the hands and feet
* Sexual dysfunction
There is no cure for Sjögren's syndrome, but various treatments can help manage the symptoms. These may include:
* Medications to stimulate saliva production
* Eye drops to moisturize the eyes
* Mouthwashes to stimulate saliva production
* Pain relief medication for joint pain
* Anti-inflammatory medication to reduce swelling
* Immunosuppressive medication to suppress the immune system
* Hormone replacement therapy (HRT) to treat hormonal imbalances.
Sjögren's syndrome can also increase the risk of developing other autoimmune disorders, such as rheumatoid arthritis or lupus. It is important for people with Sjögren's syndrome to work closely with their healthcare provider to manage their symptoms and monitor their condition over time.
The term "systemic" refers to the fact that the disease affects multiple organ systems, including the skin, joints, kidneys, lungs, and nervous system. LES is a complex condition, and its symptoms can vary widely depending on which organs are affected. Common symptoms include fatigue, fever, joint pain, rashes, and swelling in the extremities.
There are several subtypes of LES, including:
1. Systemic lupus erythematosus (SLE): This is the most common form of the disease, and it can affect anyone, regardless of age or gender.
2. Discoid lupus erythematosus (DLE): This subtype typically affects the skin, causing a red, scaly rash that does not go away.
3. Drug-induced lupus erythematosus: This form of the disease is caused by certain medications, and it usually resolves once the medication is stopped.
4. Neonatal lupus erythematosus: This rare condition affects newborn babies of mothers with SLE, and it can cause liver and heart problems.
There is no cure for LES, but treatment options are available to manage the symptoms and prevent flares. Treatment may include nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, immunosuppressive medications, and antimalarial drugs. In severe cases, hospitalization may be necessary to monitor and treat the disease.
It is important for people with LES to work closely with their healthcare providers to manage their condition and prevent complications. With proper treatment and self-care, many people with LES can lead active and fulfilling lives.
There are several types of chromosome aberrations, including:
1. Chromosomal deletions: Loss of a portion of a chromosome.
2. Chromosomal duplications: Extra copies of a chromosome or a portion of a chromosome.
3. Chromosomal translocations: A change in the position of a chromosome or a portion of a chromosome.
4. Chromosomal inversions: A reversal of a segment of a chromosome.
5. Chromosomal amplifications: An increase in the number of copies of a particular chromosome or gene.
Chromosome aberrations can be detected through various techniques, such as karyotyping, fluorescence in situ hybridization (FISH), or array comparative genomic hybridization (aCGH). These tests can help identify changes in the chromosomal makeup of cells and provide information about the underlying genetic causes of disease.
Chromosome aberrations are associated with a wide range of diseases, including:
1. Cancer: Chromosome abnormalities are common in cancer cells and can contribute to the development and progression of cancer.
2. Birth defects: Many birth defects are caused by chromosome abnormalities, such as Down syndrome (trisomy 21), which is caused by an extra copy of chromosome 21.
3. Neurological disorders: Chromosome aberrations have been linked to various neurological disorders, including autism and intellectual disability.
4. Immunodeficiency diseases: Some immunodeficiency diseases, such as X-linked severe combined immunodeficiency (SCID), are caused by chromosome abnormalities.
5. Infectious diseases: Chromosome aberrations can increase the risk of infection with certain viruses, such as human immunodeficiency virus (HIV).
6. Ageing: Chromosome aberrations have been linked to the ageing process and may contribute to the development of age-related diseases.
7. Radiation exposure: Exposure to radiation can cause chromosome abnormalities, which can increase the risk of cancer and other diseases.
8. Genetic disorders: Many genetic disorders are caused by chromosome aberrations, such as Turner syndrome (45,X), which is caused by a missing X chromosome.
9. Rare diseases: Chromosome aberrations can cause rare diseases, such as Klinefelter syndrome (47,XXY), which is caused by an extra copy of the X chromosome.
10. Infertility: Chromosome abnormalities can contribute to infertility in both men and women.
Understanding the causes and consequences of chromosome aberrations is important for developing effective treatments and improving human health.
Bloom syndrome is a rare genetic disorder that affects approximately 1 in 100,000 individuals worldwide. It is caused by a mutation in the BLM gene, which codes for the Bloom syndrome protein (BLM). This protein plays a crucial role in the repair of DNA double-strand breaks and other types of genetic damage.
Characteristics:
Individuals with Bloom syndrome typically have short stature, small head size, and delicate features. They may also experience a range of health problems, including:
1. Increased risk of cancer: People with Bloom syndrome have an increased risk of developing various types of cancer, such as ovarian, breast, skin, and colon cancer.
2. Immune system problems: Individuals with Bloom syndrome may experience immune deficiency and autoimmune disorders, such as allergies and lupus.
3. Infertility: Many people with Bloom syndrome experience infertility or have difficulty conceiving.
4. Developmental delays: Children with Bloom syndrome may experience delayed development, including speech and language difficulties.
5. Skin changes: Individuals with Bloom syndrome may develop skin changes, such as thinning of the skin, easy bruising, and an increased risk of skin cancer.
6. Eye problems: Bloom syndrome can cause a range of eye problems, including cataracts, glaucoma, and detached retinas.
7. Increased risk of infections: People with Bloom syndrome may be more susceptible to infections due to their weakened immune system.
8. Other health problems: Individuals with Bloom syndrome may experience other health issues, such as hearing loss, kidney disease, and gastrointestinal problems.
Diagnosis:
Bloom syndrome can be diagnosed through a combination of clinical evaluation, family history, and genetic testing. Genetic testing can identify the presence of the BLM mutation that causes the disorder. Prenatal testing is also available for pregnant women who have a family history of Bloom syndrome.
Treatment:
There is no cure for Bloom syndrome, but treatment can help manage the symptoms and prevent complications. Treatment options may include:
1. Skin cancer screening and prevention: Regular skin exams can help detect skin cancer at an early stage, and preventive measures such as avoiding excessive sun exposure and using protective clothing and sunscreen can reduce the risk of skin cancer.
2. Eye care: Regular eye exams can help detect eye problems early, and prompt treatment can prevent vision loss.
3. Immune system support: Individuals with Bloom syndrome may be at increased risk of infections, so it's important to take steps to support the immune system, such as getting vaccinated against common illnesses and practicing good hygiene.
4. Developmental support: Children with Bloom syndrome may require extra support in school and at home to help them reach their full potential.
5. Managing other health problems: Depending on the specific health issues experienced by an individual with Bloom syndrome, treatment may involve medication, lifestyle changes, or other interventions to manage these conditions.
Prognosis:
The prognosis for individuals with Bloom syndrome varies depending on the specific health problems they experience. Some individuals may have a relatively mild course of the condition, while others may experience more severe health issues. With appropriate medical care and support, many individuals with Bloom syndrome can lead fulfilling lives. However, the condition can be associated with a shorter life expectancy compared to the general population.
Lifestyle Changes:
There are several lifestyle changes that can help manage the symptoms of Bloom syndrome and improve overall health. These may include:
1. Protecting the skin from the sun: Avoid excessive sun exposure, especially during peak hours, and use protective clothing and sunscreen to prevent skin damage.
2. Eating a healthy diet: A balanced diet that includes plenty of fruits, vegetables, whole grains, and lean protein can help support overall health.
3. Staying hydrated: Drinking plenty of water can help prevent dehydration, which can be a common issue for individuals with Bloom syndrome.
4. Avoiding smoking and excessive alcohol consumption: Both smoking and excessive alcohol consumption can worsen the symptoms of Bloom syndrome and increase the risk of certain health problems.
5. Getting regular exercise: Regular physical activity can help improve overall health and reduce the risk of certain health problems.
6. Managing stress: Stress can exacerbate the symptoms of Bloom syndrome, so it's important to find healthy ways to manage stress, such as through relaxation techniques or therapy.
7. Getting enough sleep: Adequate sleep is essential for overall health and well-being, and can help reduce the risk of certain health problems.
8. Avoiding exposure to toxins: Individuals with Bloom syndrome may be more susceptible to the effects of toxins, so it's important to avoid exposure to chemicals and other toxins whenever possible.
9. Keeping up-to-date on medical care: Regular check-ups with a healthcare provider can help identify any health issues early on and prevent complications.
Support Groups:
There are several support groups and organizations that provide information, resources, and support for individuals with Bloom syndrome and their families. These include:
1. The National Organization for Rare Disorders (NORD) - Provides information and resources on rare diseases, including Bloom syndrome.
2. The Bloom Syndrome Foundation - A non-profit organization dedicated to supporting research and providing information and resources for individuals with Bloom syndrome and their families.
3. The Rare Disease United Foundation - Provides information and resources on rare diseases, including Bloom syndrome, as well as support for individuals and families affected by these conditions.
Online Resources:
There are several online resources available to help individuals with Bloom syndrome and their families learn more about the condition, connect with others, and find support. These include:
1. The National Organization for Rare Disorders (NORD) - Provides information and resources on rare diseases, including Bloom syndrome, as well as a directory of healthcare providers and researchers.
2. The Bloom Syndrome Foundation - Offers information and resources on Bloom syndrome, as well as a registry for individuals with the condition to connect with others and receive updates on research and treatments.
3. Rare Disease United - Provides information and resources on rare diseases, including Bloom syndrome, as well as a directory of support groups and advocacy organizations.
4. The Global Bloom Syndrome Registry - A registry for individuals with Bloom syndrome to connect with others and receive updates on research and treatments.
5. The Bloom Syndrome Community - A Facebook group for individuals with Bloom syndrome and their families to connect, share information, and support one another.
These online resources can provide valuable information and support for individuals with Bloom syndrome and their families. It is important to note that while these resources can be helpful, they should not replace the advice of a qualified healthcare professional.
UC can be challenging to diagnose and treat, and there is no known cure. However, with proper management, it is possible for people with UC to experience long periods of remission and improve their quality of life. Treatment options include medications such as aminosalicylates, corticosteroids, and immunomodulators, as well as surgery in severe cases.
It's important for individuals with UC to work closely with their healthcare provider to develop a personalized treatment plan that takes into account their specific symptoms and needs. With the right treatment and support, many people with UC are able to manage their symptoms and lead active, fulfilling lives.
There are currently no cures for Fanconi anemia, but bone marrow transplantation and other supportive therapies can help manage some of the symptoms and improve quality of life. Research into the genetics and molecular biology of Fanconi anemia is ongoing to better understand the disorder and develop new treatments.
Some of the common symptoms of Fanconi anemia include short stature, limb deformities, hearing loss, vision problems, and an increased risk of infections and cancer. Children with Fanconi anemia may also experience developmental delays, learning disabilities, and social and emotional challenges.
The diagnosis of Fanconi anemia is typically made based on a combination of clinical findings, laboratory tests, and genetic analysis. Treatment options for Fanconi anemia depend on the severity of the disorder and may include bone marrow transplantation, blood transfusions, antibiotics, and other supportive therapies.
Fanconi anemia is a rare disorder that affects approximately 1 in 160,000 births worldwide. It is more common in certain populations, such as Ashkenazi Jews and individuals of Spanish descent. Fanconi anemia can be inherited in an autosomal recessive pattern, meaning that a child must inherit two copies of the mutated gene (one from each parent) to develop the disorder.
Overall, Fanconi anemia is a complex and rare genetic disorder that requires specialized medical care and ongoing research to better understand its causes and develop effective treatments. With appropriate management and supportive therapies, individuals with Fanconi anemia can lead fulfilling lives despite the challenges associated with the disorder.
There are several key features of inflammation:
1. Increased blood flow: Blood vessels in the affected area dilate, allowing more blood to flow into the tissue and bringing with it immune cells, nutrients, and other signaling molecules.
2. Leukocyte migration: White blood cells, such as neutrophils and monocytes, migrate towards the site of inflammation in response to chemical signals.
3. Release of mediators: Inflammatory mediators, such as cytokines and chemokines, are released by immune cells and other cells in the affected tissue. These molecules help to coordinate the immune response and attract more immune cells to the site of inflammation.
4. Activation of immune cells: Immune cells, such as macrophages and T cells, become activated and start to phagocytose (engulf) pathogens or damaged tissue.
5. Increased heat production: Inflammation can cause an increase in metabolic activity in the affected tissue, leading to increased heat production.
6. Redness and swelling: Increased blood flow and leakiness of blood vessels can cause redness and swelling in the affected area.
7. Pain: Inflammation can cause pain through the activation of nociceptors (pain-sensing neurons) and the release of pro-inflammatory mediators.
Inflammation can be acute or chronic. Acute inflammation is a short-term response to injury or infection, which helps to resolve the issue quickly. Chronic inflammation is a long-term response that can cause ongoing damage and diseases such as arthritis, asthma, and cancer.
There are several types of inflammation, including:
1. Acute inflammation: A short-term response to injury or infection.
2. Chronic inflammation: A long-term response that can cause ongoing damage and diseases.
3. Autoimmune inflammation: An inappropriate immune response against the body's own tissues.
4. Allergic inflammation: An immune response to a harmless substance, such as pollen or dust mites.
5. Parasitic inflammation: An immune response to parasites, such as worms or fungi.
6. Bacterial inflammation: An immune response to bacteria.
7. Viral inflammation: An immune response to viruses.
8. Fungal inflammation: An immune response to fungi.
There are several ways to reduce inflammation, including:
1. Medications such as nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and disease-modifying anti-rheumatic drugs (DMARDs).
2. Lifestyle changes, such as a healthy diet, regular exercise, stress management, and getting enough sleep.
3. Alternative therapies, such as acupuncture, herbal supplements, and mind-body practices.
4. Addressing underlying conditions, such as hormonal imbalances, gut health issues, and chronic infections.
5. Using anti-inflammatory compounds found in certain foods, such as omega-3 fatty acids, turmeric, and ginger.
It's important to note that chronic inflammation can lead to a range of health problems, including:
1. Arthritis
2. Diabetes
3. Heart disease
4. Cancer
5. Alzheimer's disease
6. Parkinson's disease
7. Autoimmune disorders, such as lupus and rheumatoid arthritis.
Therefore, it's important to manage inflammation effectively to prevent these complications and improve overall health and well-being.
People with LFS have a high risk of developing cancer at an early age, often before the age of 40. The syndrome is usually diagnosed in individuals who have a family history of breast cancer, ovarian cancer, or soft tissue sarcomas.
The signs and symptoms of LFS can vary depending on the type of cancer that develops, but may include:
* Breast cancer: A lump or thickening in the breast, change in the size or shape of the breast, or nipple discharge
* Ovarian cancer: Abdominal pain, bloating, or swelling, difficulty eating or feeling full quickly
* Soft tissue sarcomas: A soft tissue mass or lump, often in the arm or leg
There is no cure for LFS, but regular monitoring and screening can help to detect cancer early, when it is most treatable. Treatment for cancer in LFS typically involves surgery, chemotherapy, and/or radiation therapy.
The prognosis for individuals with LFS varies depending on the type of cancer that develops and the age at which it is diagnosed. In general, the earlier cancer is detected and treated, the better the prognosis. However, the syndrome can be challenging to diagnose, as the symptoms can be nonspecific and may not appear until late in the disease process.
There is currently no cure for Li-Fraumeni Syndrome, but researchers are working to develop new treatments and improve early detection methods. Individuals with a family history of LFS or breast cancer should speak with their healthcare provider about genetic testing and counseling to determine if they may be at risk for the syndrome.
Crohn's disease can affect any part of the GI tract, from the mouth to the anus, and causes symptoms such as abdominal pain, diarrhea, fatigue, and weight loss. Ulcerative colitis primarily affects the colon and rectum and causes symptoms such as bloody stools, abdominal pain, and weight loss.
Both Crohn's disease and ulcerative colitis are chronic conditions, meaning they cannot be cured but can be managed with medication and lifestyle changes. Treatment options for IBD include anti-inflammatory medications, immunosuppressants, and biologics. In severe cases, surgery may be necessary to remove damaged portions of the GI tract.
There is no known cause of IBD, although genetics, environmental factors, and an abnormal immune response are thought to play a role. The condition can have a significant impact on quality of life, particularly if left untreated or poorly managed. Complications of IBD include malnutrition, osteoporosis, and increased risk of colon cancer.
Preventing and managing IBD requires a comprehensive approach that includes medication, dietary changes, stress management, and regular follow-up with a healthcare provider. With proper treatment and lifestyle modifications, many people with IBD are able to manage their symptoms and lead active, fulfilling lives.
The causes of colorectal neoplasms are not fully understood, but factors such as age, genetics, diet, and lifestyle have been implicated. Symptoms of colorectal cancer can include changes in bowel habits, blood in the stool, abdominal pain, and weight loss. Screening for colorectal cancer is recommended for adults over the age of 50, as it can help detect early-stage tumors and improve survival rates.
There are several subtypes of colorectal neoplasms, including adenomas (which are precancerous polyps), carcinomas (which are malignant tumors), and lymphomas (which are cancers of the immune system). Treatment options for colorectal cancer depend on the stage and location of the tumor, but may include surgery, chemotherapy, radiation therapy, or a combination of these.
Research into the causes and treatment of colorectal neoplasms is ongoing, and there has been significant progress in recent years. Advances in screening and treatment have improved survival rates for patients with colorectal cancer, and there is hope that continued research will lead to even more effective treatments in the future.
Body weight is an important health indicator, as it can affect an individual's risk for certain medical conditions, such as obesity, diabetes, and cardiovascular disease. Maintaining a healthy body weight is essential for overall health and well-being, and there are many ways to do so, including a balanced diet, regular exercise, and other lifestyle changes.
There are several ways to measure body weight, including:
1. Scale: This is the most common method of measuring body weight, and it involves standing on a scale that displays the individual's weight in kg or lb.
2. Body fat calipers: These are used to measure body fat percentage by pinching the skin at specific points on the body.
3. Skinfold measurements: This method involves measuring the thickness of the skin folds at specific points on the body to estimate body fat percentage.
4. Bioelectrical impedance analysis (BIA): This is a non-invasive method that uses electrical impulses to measure body fat percentage.
5. Dual-energy X-ray absorptiometry (DXA): This is a more accurate method of measuring body composition, including bone density and body fat percentage.
It's important to note that body weight can fluctuate throughout the day due to factors such as water retention, so it's best to measure body weight at the same time each day for the most accurate results. Additionally, it's important to use a reliable scale or measuring tool to ensure accurate measurements.
There are several types of lung neoplasms, including:
1. Adenocarcinoma: This is the most common type of lung cancer, accounting for approximately 40% of all lung cancers. It is a malignant tumor that originates in the glands of the respiratory tract and can be found in any part of the lung.
2. Squamous cell carcinoma: This type of lung cancer accounts for approximately 25% of all lung cancers and is more common in men than women. It is a malignant tumor that originates in the squamous cells lining the airways of the lungs.
3. Small cell lung cancer (SCLC): This is a highly aggressive form of lung cancer that accounts for approximately 15% of all lung cancers. It is often found in the central parts of the lungs and can spread quickly to other parts of the body.
4. Large cell carcinoma: This is a rare type of lung cancer that accounts for only about 5% of all lung cancers. It is a malignant tumor that originates in the large cells of the respiratory tract and can be found in any part of the lung.
5. Bronchioalveolar carcinoma (BAC): This is a rare type of lung cancer that originates in the cells lining the airways and alveoli of the lungs. It is more common in women than men and tends to affect older individuals.
6. Lymphangioleiomyomatosis (LAM): This is a rare, progressive, and often fatal lung disease that primarily affects women of childbearing age. It is characterized by the growth of smooth muscle-like cells in the lungs and can lead to cysts, lung collapse, and respiratory failure.
7. Hamartoma: This is a benign tumor that originates in the tissue of the lungs and is usually found in children. It is characterized by an overgrowth of normal lung tissue and can be treated with surgery.
8. Secondary lung cancer: This type of cancer occurs when cancer cells from another part of the body spread to the lungs through the bloodstream or lymphatic system. It is more common in people who have a history of smoking or exposure to other carcinogens.
9. Metastatic cancer: This type of cancer occurs when cancer cells from another part of the body spread to the lungs through the bloodstream or lymphatic system. It is more common in people who have a history of smoking or exposure to other carcinogens.
10. Mesothelioma: This is a rare and aggressive form of cancer that originates in the lining of the lungs or abdomen. It is caused by asbestos exposure and can be treated with surgery, chemotherapy, and radiation therapy.
Lung diseases can also be classified based on their cause, such as:
1. Infectious diseases: These are caused by bacteria, viruses, or other microorganisms and can include pneumonia, tuberculosis, and bronchitis.
2. Autoimmune diseases: These are caused by an overactive immune system and can include conditions such as sarcoidosis and idiopathic pulmonary fibrosis.
3. Genetic diseases: These are caused by inherited mutations in genes that affect the lungs and can include cystic fibrosis and primary ciliary dyskinesia.
4. Environmental diseases: These are caused by exposure to harmful substances such as tobacco smoke, air pollution, and asbestos.
5. Radiological diseases: These are caused by exposure to ionizing radiation and can include conditions such as radiographic breast cancer and lung cancer.
6. Vascular diseases: These are caused by problems with the blood vessels in the lungs and can include conditions such as pulmonary embolism and pulmonary hypertension.
7. Tumors: These can be benign or malignant and can include conditions such as lung metastases and lung cancer.
8. Trauma: This can include injuries to the chest or lungs caused by accidents or other forms of trauma.
9. Congenital diseases: These are present at birth and can include conditions such as bronchopulmonary foregut malformations and congenital cystic adenomatoid malformation.
Each type of lung disease has its own set of symptoms, diagnosis, and treatment options. It is important to seek medical attention if you experience any persistent or severe respiratory symptoms, as early diagnosis and treatment can improve outcomes and quality of life.
Adenocarcinoma is a term used to describe a variety of different types of cancer that arise in glandular tissue, including:
1. Colorectal adenocarcinoma (cancer of the colon or rectum)
2. Breast adenocarcinoma (cancer of the breast)
3. Prostate adenocarcinoma (cancer of the prostate gland)
4. Pancreatic adenocarcinoma (cancer of the pancreas)
5. Lung adenocarcinoma (cancer of the lung)
6. Thyroid adenocarcinoma (cancer of the thyroid gland)
7. Skin adenocarcinoma (cancer of the skin)
The symptoms of adenocarcinoma depend on the location of the cancer and can include:
1. Blood in the stool or urine
2. Abdominal pain or discomfort
3. Changes in bowel habits
4. Unusual vaginal bleeding (in the case of endometrial adenocarcinoma)
5. A lump or thickening in the breast or elsewhere
6. Weight loss
7. Fatigue
8. Coughing up blood (in the case of lung adenocarcinoma)
The diagnosis of adenocarcinoma is typically made through a combination of imaging tests, such as CT scans, MRI scans, and PET scans, and a biopsy, which involves removing a sample of tissue from the affected area and examining it under a microscope for cancer cells.
Treatment options for adenocarcinoma depend on the location of the cancer and can include:
1. Surgery to remove the tumor
2. Chemotherapy, which involves using drugs to kill cancer cells
3. Radiation therapy, which involves using high-energy X-rays or other particles to kill cancer cells
4. Targeted therapy, which involves using drugs that target specific molecules on cancer cells to kill them
5. Immunotherapy, which involves using drugs that stimulate the immune system to fight cancer cells.
The prognosis for adenocarcinoma is generally good if the cancer is detected and treated early, but it can be more challenging to treat if the cancer has spread to other parts of the body.
The hallmark symptoms of AT are:
1. Ataxia: difficulty with coordination, balance, and gait.
2. Telangiectasias: small, red blood vessels visible on the skin, particularly on the face, neck, and arms.
3. Ocular telangiectasias: small, red blood vessels visible in the eyes.
4. Cognitive decline: difficulty with memory, learning, and concentration.
5. Seizures: episodes of abnormal electrical activity in the brain.
6. Increased risk of cancer: particularly lymphoma, myeloid leukemia, and breast cancer.
The exact cause of AT is not yet fully understood, but it is thought to be due to mutations in the ATM gene, which is involved in DNA damage response and repair. There is currently no cure for AT, but various treatments are available to manage its symptoms and prevent complications. These may include:
1. Physical therapy: to improve coordination and balance.
2. Occupational therapy: to assist with daily activities and fine motor skills.
3. Speech therapy: to improve communication and swallowing difficulties.
4. Medications: to control seizures, tremors, and other symptoms.
5. Cancer screening: regular monitoring for the development of cancer.
AT is a rare disorder, and it is estimated that only about 1 in 40,000 to 1 in 100,000 individuals are affected worldwide. It is important for healthcare providers to be aware of AT and its symptoms, as early diagnosis and intervention can improve outcomes for patients with this condition.
1. Coronary artery disease: The narrowing or blockage of the coronary arteries, which supply blood to the heart.
2. Heart failure: A condition in which the heart is unable to pump enough blood to meet the body's needs.
3. Arrhythmias: Abnormal heart rhythms that can be too fast, too slow, or irregular.
4. Heart valve disease: Problems with the heart valves that control blood flow through the heart.
5. Heart muscle disease (cardiomyopathy): Disease of the heart muscle that can lead to heart failure.
6. Congenital heart disease: Defects in the heart's structure and function that are present at birth.
7. Peripheral artery disease: The narrowing or blockage of blood vessels that supply oxygen and nutrients to the arms, legs, and other organs.
8. Deep vein thrombosis (DVT): A blood clot that forms in a deep vein, usually in the leg.
9. Pulmonary embolism: A blockage in one of the arteries in the lungs, which can be caused by a blood clot or other debris.
10. Stroke: A condition in which there is a lack of oxygen to the brain due to a blockage or rupture of blood vessels.
The main clinical features of Rothmund-Thomson Syndrome include:
1. Congenital anomalies: Individuals with RTS are born with a variety of physical abnormalities such as short stature, microcephaly (small head), and facial dysmorphism (abnormal facial features).
2. Skin abnormalities: The skin is thin, delicate, and susceptible to infections, blistering, and scarring. Individuals with RTS may develop poikiloderma (a condition characterized by irregularly pigmented patches on the skin).
3. Skeletal abnormalities: RTS can cause a range of skeletal defects such as short or missing limbs, joint deformities, and spinal abnormalities.
4. Craniofacial abnormalities: The syndrome can also result in craniofacial abnormalities such as micrognathia (small jaw), protruding eyes, and hearing loss.
5. Developmental delays: Individuals with RTS often experience developmental delays and intellectual disability. They may have difficulty with speech, language, and social interactions.
6. Increased risk of cancer: People with Rothmund-Thomson Syndrome have an increased risk of developing certain types of cancer, particularly osteosarcoma (bone cancer) and rhabdomyosarcoma (soft tissue cancer).
7. Autoimmune disorders: RTS can also lead to autoimmune disorders such as thyroiditis (inflammation of the thyroid gland) and vitiligo (loss of skin pigmentation).
8. Poor immune function: The syndrome can cause poor immune function, making individuals more susceptible to infections and less able to fight them off effectively.
9. Neurological problems: RTS can result in neurological issues such as seizures, tremors, and loss of coordination.
10. Short stature: Adults with Rothmund-Thomson Syndrome often have short stature and may experience delayed or arrested growth.
It's important to note that not all individuals with RTS will experience all of these symptoms, and the severity of the syndrome can vary widely from person to person. Treatment for Rothmund-Thomson Syndrome typically involves a multidisciplinary approach, including medical management, surgical interventions, and supportive care to address the various physical and developmental challenges associated with the condition.
The APC gene is a tumor suppressor gene that helps regulate cell growth and prevent the formation of tumors. Mutations in the APC gene can cause the development of adenomas, which are precancerous growths that can eventually become colon cancer if left untreated.
APC mutations can be inherited from one's parents or can occur spontaneously. The risk of developing colorectal cancer is increased in people with an APC mutation, and regular screening and monitoring is recommended to detect and remove any precancerous growths before they become cancerous.
Symptoms of APC may include abdominal pain, diarrhea, rectal bleeding, and weight loss. Treatment for APC typically involves removal of the affected portion of the colon and rectum, followed by ongoing monitoring and screening to detect any recurrences.
In summary, adenomatous polyposis coli (APC) is a genetic condition that increases the risk of developing colorectal cancer and other cancers. It is caused by mutations in the APC gene and can be inherited or acquired spontaneously. Symptoms may include abdominal pain, diarrhea, rectal bleeding, and weight loss, and treatment typically involves removal of the affected portion of the colon and rectum, followed by ongoing monitoring and screening.
HNPCC is caused by mutations in genes involved in DNA repair, specifically in the MLH1, MSH2, MSH6, PMS2, and EPCAM genes. These genes help to repair mistakes that occur during DNA replication and repair. When these genes are mutated, the cells in the colon do not function properly and can develop into cancer.
The symptoms of HNPCC can vary depending on the location and size of the polyps, but may include:
* Blood in the stool
* Changes in bowel movements, such as diarrhea or constipation
* Abdominal pain or discomfort
* Weakness and fatigue
HNPCC is diagnosed through a combination of clinical criteria, family history, and genetic testing. Genetic testing can identify specific mutations in the genes associated with HNPCC.
Treatment for HNPCC typically involves surveillance and monitoring to detect and remove polyps before they become cancerous. This may include regular colonoscopies, endoscopies, and imaging tests such as CT scans or MRI. In some cases, surgery may be necessary to remove the affected portion of the colon or rectum.
The prognosis for HNPCC is generally poor, with a high risk of developing colorectal cancer and other cancers. However, early detection and removal of polyps can improve outcomes. It is important for individuals with HNPCC to follow their treatment plans closely and to be monitored regularly by a healthcare provider.
In summary, hereditary nonpolyposis colorectal neoplasia (HNPCC) is a rare inherited condition that increases the risk of developing colorectal cancer and other types of cancer. It is caused by mutations in genes involved in DNA repair and surveillance, and can be diagnosed through clinical criteria, family history, and genetic testing. Treatment typically involves surveillance and monitoring, with surgery may be necessary in some cases. The prognosis for HNPCC is generally poor, but early detection and removal of polyps can improve outcomes.
There are several factors that can contribute to the development of insulin resistance, including:
1. Genetics: Insulin resistance can be inherited, and some people may be more prone to developing the condition based on their genetic makeup.
2. Obesity: Excess body fat, particularly around the abdominal area, can contribute to insulin resistance.
3. Physical inactivity: A sedentary lifestyle can lead to insulin resistance.
4. Poor diet: Consuming a diet high in refined carbohydrates and sugar can contribute to insulin resistance.
5. Other medical conditions: Certain medical conditions, such as polycystic ovary syndrome (PCOS) and Cushing's syndrome, can increase the risk of developing insulin resistance.
6. Medications: Certain medications, such as steroids and some antipsychotic drugs, can increase insulin resistance.
7. Hormonal imbalances: Hormonal changes during pregnancy or menopause can lead to insulin resistance.
8. Sleep apnea: Sleep apnea can contribute to insulin resistance.
9. Chronic stress: Chronic stress can lead to insulin resistance.
10. Aging: Insulin resistance tends to increase with age, particularly after the age of 45.
There are several ways to diagnose insulin resistance, including:
1. Fasting blood sugar test: This test measures the level of glucose in the blood after an overnight fast.
2. Glucose tolerance test: This test measures the body's ability to regulate blood sugar levels after consuming a sugary drink.
3. Insulin sensitivity test: This test measures the body's ability to respond to insulin.
4. Homeostatic model assessment (HOMA): This is a mathematical formula that uses the results of a fasting glucose and insulin test to estimate insulin resistance.
5. Adiponectin test: This test measures the level of adiponectin, a protein produced by fat cells that helps regulate blood sugar levels. Low levels of adiponectin are associated with insulin resistance.
There is no cure for insulin resistance, but it can be managed through lifestyle changes and medication. Lifestyle changes include:
1. Diet: A healthy diet that is low in processed carbohydrates and added sugars can help improve insulin sensitivity.
2. Exercise: Regular physical activity, such as aerobic exercise and strength training, can improve insulin sensitivity.
3. Weight loss: Losing weight, particularly around the abdominal area, can improve insulin sensitivity.
4. Stress management: Strategies to manage stress, such as meditation or yoga, can help improve insulin sensitivity.
5. Sleep: Getting adequate sleep is important for maintaining healthy insulin levels.
Medications that may be used to treat insulin resistance include:
1. Metformin: This is a commonly used medication to treat type 2 diabetes and improve insulin sensitivity.
2. Thiazolidinediones (TZDs): These medications, such as pioglitazone, improve insulin sensitivity by increasing the body's ability to use insulin.
3. Sulfonylureas: These medications stimulate the release of insulin from the pancreas, which can help improve insulin sensitivity.
4. DPP-4 inhibitors: These medications, such as sitagliptin, work by reducing the breakdown of the hormone incretin, which helps to increase insulin secretion and improve insulin sensitivity.
5. GLP-1 receptor agonists: These medications, such as exenatide, mimic the action of the hormone GLP-1 and help to improve insulin sensitivity.
It is important to note that these medications may have side effects, so it is important to discuss the potential benefits and risks with your healthcare provider before starting treatment. Additionally, lifestyle modifications such as diet and exercise can also be effective in improving insulin sensitivity and managing blood sugar levels.
Asthma can cause recurring episodes of wheezing, coughing, chest tightness, and shortness of breath. These symptoms occur when the muscles surrounding the airways contract, causing the airways to narrow and swell. This can be triggered by exposure to environmental allergens or irritants such as pollen, dust mites, pet dander, or respiratory infections.
There is no cure for asthma, but it can be managed with medication and lifestyle changes. Treatment typically includes inhaled corticosteroids to reduce inflammation, bronchodilators to open up the airways, and rescue medications to relieve symptoms during an asthma attack.
Asthma is a common condition that affects people of all ages, but it is most commonly diagnosed in children. According to the American Lung Association, more than 25 million Americans have asthma, and it is the third leading cause of hospitalization for children under the age of 18.
While there is no cure for asthma, early diagnosis and proper treatment can help manage symptoms and improve quality of life for those affected by the condition.
The main features of PJS include:
* Multiple hamartomas in the gastrointestinal tract, which can lead to abdominal pain, nausea, vomiting, and rectal bleeding.
* Hamartomas in the lungs, which can cause coughing, wheezing, and shortness of breath.
* Hamartomas in the sex organs, which can lead to infertility, irregular menstrual cycles, and breast tumors.
* An increased risk of developing various types of cancer, including colon, lung, pancreatic, and breast cancer.
* A characteristic "speckled" appearance of the skin, caused by the accumulation of pigmented cells.
PJS is usually diagnosed in children or young adults, and it affects approximately 1 in 250,000 to 1 in 500,000 individuals worldwide. There is no cure for PJS, but regular monitoring and surveillance can help detect and treat hamartomas and cancerous lesions early on. Treatment options may include surgery, chemotherapy, and radiation therapy, depending on the location and severity of the tumors.
The main symptoms of NBS include:
* Microcephaly (a small head)
* Growth retardation
* Immune deficiency
* Neurological problems, such as seizures and developmental delays
* Skeletal abnormalities, such as short limbs and joint deformities
* Skin changes, such as a wrinkled appearance and increased risk of skin cancer
NBS is usually diagnosed through genetic testing, and treatment is focused on managing the symptoms and preventing complications. This may include physical therapy to improve mobility and strength, medication to control seizures, and antibiotics to prevent infections. In some cases, bone marrow transplantation may be recommended to restore immune function.
The prognosis for NBS is generally poor, with many individuals experiencing significant disability and a shortened lifespan. However, with appropriate medical care and support, some individuals with NBS can lead relatively normal lives.
The two main types of neurofibromatoses are:
1. Neurofibromatosis type 1 (NF1): This is the most common form of the disorder, affecting about 1 in 3,000 to 1 in 4,000 individuals. It is caused by a mutation in the NF1 gene, which is responsible for producing a protein that regulates cell growth and development.
2. Neurofibromatosis type 2 (NF2): This form of the disorder is less common, affecting about 1 in 25,000 to 1 in 30,000 individuals. It is caused by a mutation in the NF2 gene, which is also responsible for producing a protein that regulates cell growth and development.
Neurofibromatoses can cause a variety of symptoms, including:
* Skin changes such as freckling, skin thickening, and darker skin color
* Tumors on the skin or nervous system
* Learning disabilities, intellectual disability, and behavioral problems
* Skeletal abnormalities such as scoliosis (curvature of the spine) and other bone deformities
* Hearing loss and vision problems
* Increased risk of developing cancer, particularly in the brain and nervous system
There is no cure for neurofibromatoses, but treatment options are available to manage symptoms and prevent complications. These may include:
* Monitoring by a healthcare team to detect and treat any tumors or other abnormalities early
* Medications to control seizures, pain, and other symptoms
* Surgery to remove tumors or correct physical abnormalities
* Speech therapy and other supportive therapies to help with learning disabilities and other developmental delays.
It's important for individuals with neurofibromatoses to receive regular medical care and monitoring throughout their lives to manage their condition and prevent complications. With appropriate treatment and support, many individuals with neurofibromatoses can lead fulfilling lives.
People with Werner Syndrome typically have a normal intelligence and development during early childhood, but they experience a decline in physical and cognitive abilities as they age. They may also have an increased risk of developing certain cancers, such as lung and ovarian cancer. There is currently no cure for Werner Syndrome, and treatment is focused on managing the symptoms and preventing complications.
The primary diagnostic criteria for Werner Syndrome include:
1. Clinical manifestations of premature aging, such as wrinkled skin, graying hair, and short stature.
2. Normal intelligence and development during early childhood, followed by a decline in physical and cognitive abilities with age.
3. Presence of at least two of the following clinical features:
* Telangiectasias (spider veins)
* Ectropion (outward turning of the eyelids)
* Keratoconjunctivitis sicca (dry eyes)
* Poikilodermatous skin changes (skin thickening and pigmentation)
* Mucosal dryness and atrophy (thinning and drying of the mucous membranes)
4. Presence of a WRN gene mutation, confirmed by genetic testing.
The age of onset and severity of Werner Syndrome can vary widely among affected individuals, but most people experience symptoms within the first few years of life. The disorder is usually diagnosed in childhood or adolescence, based on clinical evaluation and genetic testing.
There is currently no cure for Werner Syndrome, and treatment is focused on managing the symptoms and preventing complications. This may include medication to manage dry eyes and skin, physical therapy to maintain joint mobility, and regular monitoring of the eyes and skin for early detection of any changes or problems. In some cases, surgery may be necessary to correct eye or skin problems.
Werner Syndrome is a rare disorder, and there is ongoing research into its causes and potential treatments. With proper management, many people with Werner Syndrome can lead active and fulfilling lives, despite the challenges posed by the disorder.
Epidemiology:
BCNS affects approximately 1 in 50,000-100,000 individuals worldwide and is more common in people with fair skin and light hair. The syndrome can be inherited in an autosomal dominant pattern, meaning that a single copy of the mutated gene is enough to cause the condition.
Clinical Features:
BCNS is characterized by a wide range of clinical features that affect the skin and nervous system. Skin manifestations include multiple BCCs, which can be flat or raised, flesh-colored or pigmented, and may ulcerate or bleed easily. Other skin changes include palmoplantar keratoses (thickened patches of skin on the palms and soles), papillomatoses (warts-like growths), and a higher risk of developing squamous cell carcinoma (SCC).
Nervous system manifestations can include:
1. Meningiomas: benign tumors that arise from the membranes covering the brain and spinal cord.
2. Optic gliomas: benign tumors that affect the nerves responsible for vision.
3. Hydrocephalus: accumulation of fluid in the brain, which can cause headaches, nausea, and developmental delays.
4. Plexiform neurofibromas: rare tumors that affect the nerve tissue and can cause a range of symptoms depending on their location.
Diagnosis:
BCNS is diagnosed based on a combination of clinical features and genetic testing. Genetic testing can identify mutations in the PTCH1, SUFU, or other genes associated with BCNS. Imaging studies, such as CT or MRI scans, may be used to evaluate the extent of the tumors and other manifestations of the condition.
Treatment and management:
There is no cure for BCNS, but various treatments can help manage the symptoms and slow the progression of the condition. These may include:
1. Surgery: to remove tumors or other affected tissue.
2. Chemotherapy: to reduce the growth of tumors and slow their growth.
3. Radiation therapy: to kill cancer cells and shrink tumors.
4. Pain management: to relieve pain and discomfort associated with the condition.
5. Physical therapy: to improve mobility and strength in affected limbs.
6. Monitoring: regular check-ups with a healthcare provider to monitor the progression of the condition and adjust treatment as needed.
Prognosis:
The prognosis for BCNS varies depending on the severity of the condition and the presence of certain symptoms. In general, the earlier the diagnosis and treatment, the better the prognosis. Some individuals with BCNS may experience a slow progression of the condition, while others may experience more rapid progression.
Lifestyle changes:
There are no specific lifestyle changes that can cure BCNS, but certain changes may help manage the symptoms and improve quality of life. These may include:
1. Avoiding activities that exacerbate pain or fatigue.
2. Maintaining a healthy diet to support overall health and well-being.
3. Getting regular exercise to maintain muscle strength and flexibility.
4. Managing stress through relaxation techniques, such as meditation or deep breathing.
5. Avoiding smoking and limiting alcohol intake to reduce the risk of complications.
Current research:
Research into the causes and management of BCNS is ongoing, with a focus on developing new treatments and improving existing ones. Some current areas of research include:
1. Genetic research: to better understand the genetic factors that contribute to BCNS and develop targeted therapies.
2. Immunotherapy: to harness the power of the immune system to fight cancer.
3. Precision medicine: to tailor treatment to the specific needs of each individual patient.
4. Clinical trials: to evaluate new treatments and compare them to existing ones.
Overall, while there is currently no cure for BCNS, there are various treatment options available that can help manage symptoms and improve quality of life. Ongoing research offers hope for the development of new and more effective therapies in the future.
The main features of BWS include:
1. Macroglossia (enlarged tongue): This is the most common feature of BWS, and it can cause difficulty with speaking and breathing.
2. Protruding ears: Children with BWS often have large ears that stick out from their head.
3. Omphalocele: This is a birth defect in which the intestines or other organs protrude through the navel.
4. Hydrocephalus: This is a build-up of fluid in the brain, which can cause increased pressure and enlargement of the head.
5. Polyhydramnios: This is a condition in which there is too much amniotic fluid surrounding the fetus during pregnancy.
6. Imperforate anus: This is a birth defect in which the anus is not properly formed, leading to difficulty with bowel movements.
7. Developmental delays: Children with BWS may experience delays in reaching developmental milestones, such as sitting, standing, and walking.
8. Intellectual disability: Some individuals with BWS may have mild to moderate intellectual disability.
9. Increased risk of cancer: Individuals with BWS have an increased risk of developing certain types of cancer, particularly Wilms tumor (a type of kidney cancer) and hepatoblastoma (a type of liver cancer).
There is no cure for Beckwith-Wiedemann Syndrome, but various treatments can be used to manage the associated symptoms and prevent complications. These may include surgery, physical therapy, speech therapy, and medication. With appropriate medical care and support, individuals with BWS can lead fulfilling lives.
The main features of NF1 are:
* Neurofibromas: These are the hallmark feature of NF1. They are usually soft to the touch and have a characteristic "plexiform" or web-like appearance under a microscope.
* Skin changes: People with NF1 may have freckles, skin spots, or patches that are darker or lighter than the surrounding skin.
* Bone abnormalities: About 50% of people with NF1 will have bony deformities, such as bowed legs, curvature of the spine, or abnormal bone growth.
* Optic gliomas: These are benign tumors that grow on the nerves in the eye and can cause vision problems.
* Learning disabilities: Children with NF1 may have learning difficulties, particularly with math and memory.
* Other health problems: People with NF1 may also develop other health issues, such as high blood pressure, heart problems, or thyroid disorders.
There is no cure for NF1, but various treatments can help manage the symptoms and prevent complications. These may include surgery to remove tumors, medication to control high blood pressure or other health problems, and specialized education programs to help with learning difficulties. With appropriate care and support, people with NF1 can lead fulfilling lives.
The symptoms of HBOC can include:
* Breast cancer before age 50
* Ovarian cancer at any age
* Multiple family members with breast or ovarian cancer
* Ashkenazi Jewish ancestry
The diagnosis of HBOC is typically made through genetic testing, which can identify mutations in the BRCA1 or BRCA2 genes.
Treatment for HBOC may include:
* Surveillance: Regular breast and ovarian cancer screenings to detect cancer at an early stage
* Risk-reducing salpingo-oophorectomy: Removal of the fallopian tubes and ovaries to reduce the risk of ovarian cancer
* Risk-reducing mastectomy: Removal of the breast tissue to reduce the risk of breast cancer
* Chemoprevention: Use of medications to reduce the risk of cancer
It is important for individuals with HBOC to meet with a genetic counselor or other qualified healthcare professional to discuss their options and create a personalized plan for managing their risk.
There are several types of genomic instability, including:
1. Chromosomal instability (CIN): This refers to changes in the number or structure of chromosomes, such as aneuploidy (having an abnormal number of chromosomes) or translocations (the movement of genetic material between chromosomes).
2. Point mutations: These are changes in a single base pair in the DNA sequence.
3. Insertions and deletions: These are changes in the number of base pairs in the DNA sequence, resulting in the insertion or deletion of one or more base pairs.
4. Genomic rearrangements: These are changes in the structure of the genome, such as chromosomal breaks and reunions, or the movement of genetic material between chromosomes.
Genomic instability can arise from a variety of sources, including environmental factors, errors during DNA replication and repair, and genetic mutations. It is often associated with cancer, as cancer cells have high levels of genomic instability, which can lead to the development of resistance to chemotherapy and radiation therapy.
Research into genomic instability has led to a greater understanding of the mechanisms underlying cancer and other diseases, and has also spurred the development of new therapeutic strategies, such as targeted therapies and immunotherapies.
In summary, genomic instability is a key feature of cancer cells and is associated with various diseases, including cancer, neurodegenerative disorders, and aging. It can arise from a variety of sources and is the subject of ongoing research in the field of molecular biology.
The symptoms of retinoblastoma can vary depending on the location and size of the tumor, but may include:
* A white or colored mass in one eye
* Redness or swelling of the eye
* Sensitivity to light
* Blurred vision or vision loss
* Crossed eyes (strabismus)
* Eye pain or discomfort
Retinoblastoma is usually diagnosed with a combination of physical examination, imaging tests such as ultrasound and MRI, and genetic testing. Treatment options depend on the stage and location of the tumor, but may include:
* Chemotherapy to shrink the tumor before surgery
* Surgery to remove the tumor and/or the affected eye (enucleation)
* Radiation therapy to kill any remaining cancer cells
* Targeted therapy with drugs that specifically target cancer cells
The prognosis for retinoblastoma depends on the stage of the disease at diagnosis. If the tumor is confined to one eye and has not spread to other parts of the body, the 5-year survival rate is high (around 90%). However, if the tumor has spread to other parts of the body (known as metastatic retinoblastoma), the prognosis is much poorer.
Retinoblastoma can be inherited in an autosomal dominant pattern, meaning that a single copy of the mutated RB1 gene is enough to cause the condition. Families with a history of retinoblastoma may undergo genetic testing and counseling to determine their risk of developing the disease.
Wilms tumor accounts for about 5% of all childhood kidney cancers and usually affects only one kidney. The cancerous cells in the kidney are called blastema cells, which are immature cells that have not yet developed into normal kidney tissue.
The symptoms of Wilms tumor can vary depending on the size and location of the tumor, but they may include:
* Abdominal pain or swelling
* Blood in the urine
* Fever
* Vomiting
* Weight loss
* Loss of appetite
Wilms tumor is diagnosed through a combination of imaging tests such as ultrasound, CT scans, and MRI scans, and a biopsy to confirm the presence of cancer cells.
Treatment for Wilms tumor typically involves a combination of surgery, chemotherapy, and radiation therapy. The specific treatment plan will depend on the stage and location of the tumor, as well as the age and overall health of the child. In some cases, the affected kidney may need to be removed if the cancer is not completely removable by surgery or if it has spread to other parts of the body.
The prognosis for Wilms tumor has improved significantly over the past few decades due to advances in treatment and early detection. According to the American Cancer Society, the 5-year survival rate for children with Wilms tumor is about 90% if the cancer is diagnosed before it has spread to other parts of the body. However, the cancer can recur in some cases, especially if it has spread to other parts of the body at the time of initial diagnosis.
Overall, while Wilms tumor is a serious and potentially life-threatening condition, with prompt and appropriate treatment, many children with this disease can achieve long-term survival and a good quality of life.
Benign ovarian neoplasms include:
1. Serous cystadenoma: A fluid-filled sac that develops on the surface of the ovary.
2. Mucinous cystadenoma: A tumor that is filled with mucin, a type of protein.
3. Endometrioid tumors: Tumors that are similar to endometrial tissue (the lining of the uterus).
4. Theca cell tumors: Tumors that develop in the supportive tissue of the ovary called theca cells.
Malignant ovarian neoplasms include:
1. Epithelial ovarian cancer (EOC): The most common type of ovarian cancer, which arises from the surface epithelium of the ovary.
2. Germ cell tumors: Tumors that develop from germ cells, which are the cells that give rise to eggs.
3. Stromal sarcomas: Tumors that develop in the supportive tissue of the ovary.
Ovarian neoplasms can cause symptoms such as pelvic pain, abnormal bleeding, and abdominal swelling. They can also be detected through pelvic examination, imaging tests such as ultrasound and CT scan, and biopsy. Treatment options for ovarian neoplasms depend on the type, stage, and location of the tumor, and may include surgery, chemotherapy, and radiation therapy.
1. Costello Syndrome
2. Hyperflexible Ehlers-Danlos Syndrome (hEDS) Type 3
3. Autosomal Dominant Ehlers-Danlos Syndrome (AD-EDS) Type 3
4. Connective Tissue Disorder
5. Hypermobility Spectrum Disorder (HSD)
6. Hypermobile Ehlers-Danlos Syndrome (hEDS)
Costello syndrome is a rare genetic disorder that impacts the body's connective tissues, particularly skin, joints, and blood vessels. It is also known as hyperflexible Ehlers-Danlos syndrome or autosomal dominant Ehlers-Danlos syndrome type 3. People with this condition have extremely flexible joints, which can lead to joint dislocations and other complications. Other symptoms may include fragile skin that is prone to tearing, bruising, and poor wound healing, as well as cardiac, gastrointestinal, and neurological problems. The condition is caused by a mutation in the COL5A1 or COL5A2 genes and is inherited in an autosomal dominant pattern, meaning that a single copy of the mutated gene is sufficient to cause the condition. There is no cure for Costello syndrome, but treatment is aimed at managing symptoms and preventing complications.
Genocopy
Genetic predisposition
Equine recurrent uveitis
Heart failure
Recombinant subunit vaccine
Diffuse panbronchiolitis
Leon Eisenberg
Non-Hodgkin lymphoma
Stevens-Johnson syndrome
Hoof wall separation disease
Julius Caesar
Acne aestivalis
Connective tissue disease
Krembil Research Institute
Systemic scleroderma
Policlinico San Matteo
Recurrent laryngeal nerve
Vaccine
Coronary artery disease
Autoimmune disease
Soft-coated Wheaten Terrier
Cardiovascular disease
Lichen sclerosus
Porphyria
Orofacial granulomatosis
Hygiene hypothesis
Kikuchi disease
Allergies in cats
MYH9
Melasma
Predictive medicine
Paralytic illness of Franklin D. Roosevelt
Stephen Sutton
Sprain
Bean pod mottle virus
Afghan Hound
Alien 3
Intestinal epithelium
Sharon Moalem
The Gene: An Intimate History
PHACTR1
Opportunistic infection
Risk factor
Sexual and reproductive health
Genotyping
Caretaker gene
Risk factors of schizophrenia
Health of Filipino Americans
Sex differences in human physiology
EFEMP1
IDDM11
Lactose intolerance
Fibrocystic breast changes
Simpson-Golabi-Behmel syndrome
Keratolytic winter erythema
Dog aggression
Cholestasis
MPGES-2
Pulp stone
Child psychopathology
What does it mean to have a genetic predisposition to a disease?: MedlinePlus Genetics
"24 DNA-2 Blood Types" Invention That Determines Your Disease Predispositions, Genetic Gender, DNA, 2 Blood Types, and Much...
Pediatric Anti-GBM Disease (Goodpasture Syndrome): Background, Pathophysiology, Epidemiology
Glossary of Terms | Parkinson's Disease
Results of search for 'su:{Genetic predisposition to disease}'
›
WHO HQ Library catalog
Lipoprotein News, Research
OGPPH Publications | CDC
Factors that affect skin aging: a cohort-based survey on twins
NIOSHTIC-2 Search Results - Full View
Principles of Pediatric Environmental Health: How Does Toxic Exposure Cause Children's Disease? | Environmental Medicine | ATSDR
DeCS - Termos Novos
Breast cancer in Egypt: a review of disease presentation and detection strategies
WHO EMRO | Review: Growing burden of noncommunicable diseases: the contributory role of oral diseases, Eastern Mediterranean...
Tian Ge, Ph.D. | Harvard Catalyst Profiles | Harvard Catalyst
Yellow Fever Vaccine-Associated Viscerotropic Disease among Siblings, São Paulo State, Brazil - Volume 29, Number 3-March 2023 ...
Advanced Search Results - Public Health Image Library(PHIL)
Granulomatosis with Polyangiitis (GPA, formerly Wegener Granulomatosis): Practice Essentials, Background, Etiology
Anne E. Kwitek | Professor | Medical College of Wisconsin
Granulomatosis with Polyangiitis (GPA, formerly Wegener Granulomatosis): Practice Essentials, Background, Etiology
Moyamoya disease: Causes, symptoms, diagnosis and treatments | Health - Hindustan Times
The 5 Key Habits For Long-Term Health, According To Science
Articles, tagged with "hair roots"
DISCLAIMER: This text is not a verbatim transcript. Communication Access Real Time Translation (CART) is provided in order to...
easyDNA determines your predisposition to Graves Disease | EasyDNA India
Mail in Testing Service - SNL Transcripts Tonight
Portal Regional da BVS
Progeria in Babies | American Pregnancy Association
Yusuf Tutar | IntechOpen
FDA OKs Drug for Rare Lipid Disorder
Vitiligo Diagnosis | Skin Diseases | Dr Batra's™
Genetics6
- Genetics and public health in the 21st century : using genetic information to improve health and prevent disease / edited by Muin J. Khoury, Wylie Burke, Elizabeth J. Thomson. (who.int)
- Dr. Kwitek is an animal and human geneticist whose research revolves around the genetics of complex disease with an emphasis on hypertension, obesity, diabetes, and the metabolic syndrome (MetS). (mcw.edu)
- The approach involves integrating genetics, genomics, and other 'omics' approaches to identify genes and mechanisms leading to complex disease using rat models and human populations. (mcw.edu)
- Molecular medicine describes molecular structures and mechanisms and this chapter focuses on molecular and genetics errors of diseases. (intechopen.com)
- Timothy Caulfield, director of research at the Health Law Institute at the University of Alberta speaks of other fears: The rash of horrific predictions regarding the evils of tampering with genetics and the fears that followed the decoding of the human genome, such as an army of clones, designer babies and the creation of a genetic underclass. (lsminsurance.ca)
- The first era was the classical genetics where phenotypes of interest among family members are observed to identify segregation patterns of the "functional units" of genes or different forms of gene (alleles) and to lead to understanding of genetic mechanisms of particular phenotypes. (who.int)
Susceptibility8
- A genetic predisposition (sometimes also called genetic susceptibility) is an increased likelihood of developing a particular disease based on a person's genetic makeup. (medlineplus.gov)
- To identify environmental factors that correlate with skin photoaging, controlling for genetic susceptibility by using a questionnaire administered to twins. (nih.gov)
- The study of twins provides a unique opportunity to control for genetic susceptibility in order to elucidate environmental influences on skin aging. (nih.gov)
- Genetic susceptibility to beryllium sensitization (BeS) and chronic beryllium disease (CBD) have been recognized. (cdc.gov)
- A genetic contribution is suspected due to a strong link with ethnicity and increased prevalence among first degree relatives and more recently, among East Asians, genome wide and locus specific studies identified RNF213 (ring finger protein) gene in the 17q25-ter region as a susceptibility gene for MMD. (hindustantimes.com)
- The first involves understanding the genetic susceptibility to complex human diseases, with a focus on obesity, hypertension, diabetes, and cardiometabolic disease. (mcw.edu)
- It seems that heredity is a main factor in determining susceptibility to Graves' Disease. (easydna.in)
- A latent susceptibility to disease at the genetic level, which may be activated under certain conditions. (bvsalud.org)
Centers for Diseas4
- Centers for Disease Control and Prevention. (cdc.gov)
- In South Korea, the Korea Centers for Disease Control and Prevention (KCDC) has operated the CJD surveillance system and issued epidemiologic reports since 2001. (cdc.gov)
- The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. (cdc.gov)
- Posted on August 14, 2017 by Christine Y Lu, guest blogger, Harvard Medical School, Boston, Mass and Muin J. Khoury, Office of Public Health Genomics, Centers for Disease Control and Prevention. (cdc.gov)
20203
- In countries of the Eastern Mediterranean Region (EMR) 47% of the Region's burden of disease is currently due to NCD, and this is expected to rise to 60% by the year 2020 [2]. (who.int)
- It is predicted that by 2020 these diseases will be causing 7 out of every 10 deaths in developing countries [3] and 60% of all mortality will be attributable to NCD [4]. (who.int)
- For example, a 2020 review indicates that dietary carbohydrates and fiber can be modifiers of some genetic variants in type 2 diabetes. (medicalnewstoday.com)
Exposure7
- Principles of Pediatric Environmental Health: How Does Toxic Exposure Cause Children's Disease? (cdc.gov)
- How Does Toxic Exposure Cause Children's Disease? (cdc.gov)
- describe the exposure-disease model. (cdc.gov)
- The exposure-disease model is often used to conceptualize how toxicant exposure occurs and to identify the steps necessary to cause disease or other adverse health or developmental outcomes. (cdc.gov)
- The exposure-disease model depicts the relationship between an environmental contaminant and an adverse health effect. (cdc.gov)
- After a sufficient level of exposure (dose) to the chemical, biologic uptake, target organ contact, and biologic change can occur, all of which can lead to disease or other effects. (cdc.gov)
- Exposure: For a toxicant to cause disease, exposure must occur. (cdc.gov)
Obesity2
- Other research has shown that a plant-based diet reduces the risk of heart disease, dementia, cancer, metabolic disease, overweight and obesity, and diabetes. (forbes.com)
- There can also be a genetic role in obesity, and families often develop similar eating habits. (medicalnewstoday.com)
Syndrome6
- Goodpasture's name has been used in a more specific clinical condition known as Goodpasture disease, which is the pulmonary renal syndrome specifically associated with anti-glomerular basement membrane (anti-GBM) antibodies. (medscape.com)
- To avoid confusion between Goodpasture syndrome and Goodpasture disease, the term anti-GBM disease is used. (medscape.com)
- On the basis of this clinical report, Goodpasture's name is often linked to the pulmonary renal syndrome of alveolar hemorrhage and necrotizing and proliferative glomerulonephritis, although vasculitis and not anti-GBM disease is believed to be the cause of the pulmonary renal syndrome in Goodpasture's original patient. (medscape.com)
- When such vasculopathy is associated with any secondary causes like down syndrome, cranial irradiation, sickle cell disease, neurofibromatosis type etc, it is termed as Moyamoya Syndrome (MMS). (hindustantimes.com)
- Although some MIS-C patients have typical manifestations, others appear to have substantial overlap with acute severe COVID-19 infection in other -- and other hyper inflammatory conditions such as Kawasaki disease and toxic shock syndrome. (cdc.gov)
- Familial cold autoinflammatory syndrome (FCAS) is the mildest subtype of cryopyrin-associated periodic syndrome (CAPS) and is a rare inherited systemic autoinflammatory disease (SAID). (bvsalud.org)
Autoimmune disorder2
- Graves' disease is an autoimmune disorder of the thyroid gland that triggers overproduction of thyroid hormones. (easydna.in)
- Graves' disease, an autoimmune disorder , is the most common cause of hyperthyroidism. (healthline.com)
Disorders6
- Genetic testing uses blood and body tissues to detect genetic disorders. (lsminsurance.ca)
- When doctors identify these disorders, they can begin treatment immediately - whereas in the past, treatment would commonly not begin until signs of the genetic disease were present. (lsminsurance.ca)
- Equitable Implementation of Cascade Testing for Genetic Disorders: Where are We? (cdc.gov)
- Testing relatives of individuals with genetic disorders, a process known as cascade testing or cascade screening, is critical for identifying those needing health services that can prevent morbidity and mortality. (cdc.gov)
- For example, tests are available to check newborns for genetic disorders, screen would-be parents for carrier status, inform cancer care, and evaluate potential pharmacogenetic associations. (cdc.gov)
- CAPS is the consequence of a rare group of genetic disorders that are mostly reported in European and American populations, but scarcely reported in Chinese populations. (bvsalud.org)
Toxic2
Diagnosis3
- A recent study published in the journal Scientific Reports assessed the associations between the change in total cholesterol (TC) levels after type 2 diabetes (T2D) diagnosis (relative to pre-diagnosis levels) and the risk of cardiovascular disease (CVD). (news-medical.net)
- Stool testing can provide advanced diagnosis of harmful diseases and genetic pre-dispositions. (jt.org)
- If such discoveries, knowledge and technology gained are integrated into the health care systems in ethically, socially, economically and legally accepted ways, the increased benefits for diagnosis, prevention, promotion and treatment of many diseases, including human genetic conditions will be greatly appreciable in both developed and developing world. (who.int)
Variation1
- Some people with a predisposing genetic variation will never get the disease while others will, even within the same family. (medlineplus.gov)
Diabetes10
- ABSTRACT Associations of oral diseases with noncommunicable diseases such as diabetes, cardiovascular diseases, chronic respiratory diseases, osteoporosis and chronic renal failure are widely reported in the literature from developed countries. (who.int)
- Heart disease, stroke, cancer, diabetes and chronic respiratory disease are the leading causes of death in every region of the world [1]. (who.int)
- More than a third of us are obese, and the incidence of type 2 diabetes is going through the roof with Alzheimer's disease not far behind. (hachettebookgroup.com)
- For the first time in decades, in 2015 US life expectancy dropped due to increased deaths from heart disease, stroke, Alzheimer's, diabetes, and kidney disease. (hachettebookgroup.com)
- Is type 2 diabetes genetic? (medicalnewstoday.com)
- A person's genes can make them more susceptible to developing type 2 diabetes, and the disease has a stronger link to family history than type 1 diabetes. (medicalnewstoday.com)
- Read on to learn more about the genetic link with type 2 diabetes, which genes it can involve, and how someone might be able to influence whether they develop the disease. (medicalnewstoday.com)
- This can put someone with a genetic predisposition at more risk for developing type 2 diabetes. (medicalnewstoday.com)
- Diet and behavioral factors can influence whether a person with a genetic predisposition to type 2 diabetes develops the disease. (medicalnewstoday.com)
- The rates of hypertension, hypercholesterolemia, diabetes, hyperlipidemia, and heart disease were significantly higher in men with PD and ED compared with those with PD alone, but the authors believed that this relationship was more likely related to the ED rather than to the PD. (medscape.com)
Environmental3
- These include other genetic factors (sometimes called modifiers) as well as lifestyle and environmental factors. (medlineplus.gov)
- Although a person's genetic makeup cannot be altered, some lifestyle and environmental modifications (such as having more frequent disease screenings and maintaining a healthy weight) may be able to reduce disease risk in people with a genetic predisposition. (medlineplus.gov)
- Steps that must occur for an environmental toxicant to cause disease. (cdc.gov)
Genes4
- Particular variations in other genes, such as BARD1 and BRIP1 , also increase breast cancer risk, but the contribution of these genetic changes to a person's overall risk appears to be much smaller. (medlineplus.gov)
- Although each of these variations only slightly increases a person's risk, having changes in several different genes may combine to increase disease risk significantly. (medlineplus.gov)
- Researchers are working to calculate an individual's estimated risk for developing a common disease based on the combination of variants in many genes across their genome. (medlineplus.gov)
- Studies of families and twins indicate Graves' disease isn't caused by a single gene defect, but rather by small changes in multiple genes. (healthline.com)
Alzheimer's5
- A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 9, entitled, "Exogenous exposures shape genetic predisposition to lipids, Alzheimer's, and coronary heart disease in the MLXIPL gene locus. (news-medical.net)
- What are the genetic associations between modifiable risk factors and Alzheimer's disease? (news-medical.net)
- Researchers assessed associations between genetic risk factors and Alzheimer's. (news-medical.net)
- Importantly, exercise is also linked to a reduced risk of brain diseases like Alzheimer's disease and vascular dementia. (forbes.com)
- On the flip side, being sedentary is linked to a host of ill effects, from Alzheimer's disease to heart disease to cancer to premature death. (forbes.com)
Trait1
- The data suggest that among persons with the HLA-DPB1*E69 genetic trait, those with alleles that have a charge of -9, are at significantly (p=0.03) higher risk than those with alleles that have a charge of -7. (cdc.gov)
Pulmonary2
- Anti-GBM disease is defined as the triad of glomerulonephritis (usually rapidly progressive or crescentic), pulmonary hemorrhage, and anti-GBM antibody formation. (medscape.com)
- Despite this triad of clinical findings, patients with anti-GBM disease may present with a spectrum of conditions ranging from pulmonary hemorrhage with minimal or no renal involvement to full-blown renal failure with limited or no pulmonary involvement. (medscape.com)
Populations2
- It gives a new wave of development of biology and biomedicine, leading to new ways of prevention and control of many diseases including genetic-related diseases both for individuals, relatives and populations in larger scale. (who.int)
- Our study has enriched the understanding of the pathogenesis of FCAS, a rare disease especially in Asian populations. (bvsalud.org)
Pathogenesis2
- The pathogenesis of anti-glomerular basement membrane (anti-GBM) disease (Goodpasture disease) is linked to the presence of autoantibodies that react with the alveolus in the lung and the basement membrane of the glomerulus in the kidney. (medscape.com)
- Endothelial dysfunction is a systemic disorder and a critical element in the pathogenesis of atherosclerotic diseases and its complications. (who.int)
Systemic3
- This overview examines genetic changes, potential and established predictive and prognostic markers and end results of surgery, radiotherapy and systemic therapy for early, locally advanced and metastatic disease stages. (who.int)
- This paper reviews current knowledge on the burden and association of oral and systemic diseases, and highlights the paucity of information and research from the Eastern Mediterranean Region and other developing countries. (who.int)
- A call is made for further research to understand the status and significance of oral-systemic disease associations and develop guidelines for their control in this Region. (who.int)
Multifactorial2
- Diseases that are caused by a combination of factors are described as multifactorial . (medlineplus.gov)
- IBD in man [Crohn's disease (CD) and ulcerative colitis (UC)] can be defined as chronic idiopathic multifactorial diseases[ 2 , 3 ]. (wjgnet.com)
20171
- Direct to Consumer Genetic Testing: Think Before You Spit, 2017 Edition! (cdc.gov)
Risk13
- Current research is focused on identifying genetic changes that have a small effect on disease risk but are common in the general population. (medlineplus.gov)
- In people with a genetic predisposition, the risk of disease can depend on multiple factors in addition to an identified genetic change. (medlineplus.gov)
- The Genetic Science Learning Center at the University of Utah provides more information about calculating the risk of genetic diseases and predicting disease based on family history . (medlineplus.gov)
- The study reveals that while men with high HDL-C face an increased risk of all-cause death and cardiovascular death, this association is not observed in women without coronary artery disease. (news-medical.net)
- An exhaustive cost-benefit analysis of population genetic testing published in Annals of Internal Medicine concludes with a recommendation to U.S. health policymakers to adopt routine testing of adults ages 40 and under for three genetic conditions posing high risk of life-threatening illness. (news-medical.net)
- Previous studies revealed negative surface charge in the binding groove associated with three pairs of mostly polymorphic amino acids were associated with increasing genetic risk. (cdc.gov)
- The amount of a toxicant absorbed into the body-not how much is present in the environment-determines disease risk. (cdc.gov)
- It's not just a method of staying thin or getting fit-where exercise is really powerful is in its effects on the risk of chronic disease. (forbes.com)
- Genetic counseling is the process of determining the risk you have of passing on an inheritable disease to your baby. (americanpregnancy.org)
- As a result, the drug carries a boxed warning for a serious risk of liver toxicity because of its link to liver enzyme abnormalities and accumulation of fat in the liver, potentially leading to progressive liver disease with chronic use. (health.am)
- rather endothelial integrity depends on the balance of all cardiovascular risk factors and vasculoprotective elements in a given individual, including the genetic predisposition. (who.int)
- Thus a deep insight in to the pathophysiology of endothelium and its functions can be of value in identifying and preventing the risk factors of various cardio vascular diseases. (who.int)
- However, parents may want to know whether their child is at high risk of a rare disease even if a treatment doesn't exist. (cdc.gov)
Conditions3
- Inflammatory bowel diseases (IBD) represent important chronic conditions affecting the gastrointestinal tract in man. (wjgnet.com)
- Several health conditions can lead to hyperthyroidism, most commonly Graves' disease . (healthline.com)
- Genetic testing in children has traditionally focused on conditions with clinical actionability or utility. (cdc.gov)
Twins1
- MMD has 80% to 90% concordance in monozygotic twins which clearly denotes a genetic mechanism. (hindustantimes.com)
Symptoms2
- Many of the symptoms of Parkinson's disease are brought on by loss of or damage to dopamine neurons in this region, which encompasses the striatum, the subthalamic nucleus, and the substantia nigra. (michaeljfox.org)
- Clinical disease: physical signs and symptoms resulting from a sufficiently absorbed toxicant dose. (cdc.gov)
Stroke2
- By 2005, the total number of cardiovascular disease (CVD) deaths (mainly coronary heart disease, stroke, and rheumatic heart disease) had increased globally to 17.5 million from 14.4 million in 1990. (health.am)
- Of these, 7.6 million were attributed to coronary heart disease and 5.7 million to stroke. (health.am)
Medically1
- This is medically known as exophthalmos, and it's associated with Graves' disease. (healthline.com)
Ethical Issues1
- Genetic Screening : Ethical Issues. (who.int)
Chronic diseases2
Idiopathic1
- Moyamoya disease is defined as a rare idiopathic, progressive, bilaterally symmetrical arteriopathy of childhood , resulting in narrowing of distal ICA and proximal ACA/MCA with formation of collaterals looking like "puff of smoke" called moyamoya in Japanese and the first case report from India was reported by Dr Balasubramaniam while the first case of surgery for Moyamoya disease, Extracranial-intracranial bypass was reported by Dr Basant Misra in 1988. (hindustantimes.com)
Mechanisms2
- With models, researchers can study the mechanisms of a disease and test therapies. (michaeljfox.org)
- Diseases can be classified into deficiency diseases, hereditary diseases, infectious diseases and physiological diseases and to get a glimpse of the mechanisms the chapter covers the most common disease of each class. (intechopen.com)
Contribution1
- CaMK4 has an important function in autoimmune diseases, and the contribution of CaMK4 in psoriasis remains obscure. (bvsalud.org)
Etiology2
- Granulomatosis with polyangiitis (GPA), formerly known as Wegener granulomatosis, is a rare multisystem autoimmune disease of unknown etiology. (medscape.com)
- PD is associated with Dupuytren contractures and with HLA-B7, implying a genetic link to its etiology. (medscape.com)
Metastatic1
- The most likely primary cause of this damage is autoimmune disease , but the tissue can also be destroyed by tumors (primary or metastatic), granulomatous disease (this is an inherited primary immunodeficiency disease), or after an overdose with mitotane, a drug used to treat Cushing's disease in dogs. (dogsnaturallymagazine.com)
Occurs2
- It is a genetic condition that occurs in 1 of every 4 to 8 million newborns and manifests itself physically in children as rapid aging. (americanpregnancy.org)
- Graves' disease occurs more often in women than in men. (healthline.com)
Infectious1
- Beginning December 2010, CJD was designated as a statutory infectious disease, and KCDC conducts a complete epidemiologic investigation and monitors suspected patients. (cdc.gov)
Clinical1
- One of the cardinal clinical features of Parkinson's disease, the slowing down and loss of spontaneous and voluntary movement. (michaeljfox.org)
Fatal3
- Prion diseases are fatal, irreversible, and transmissible brain proteinopathies caused by abnormal aggregated prion protein (PrP Sc ) converted from normal prion protein (PrP C ), which is encoded by the prion protein gene ( PRNP ) ( 1 - 3 ). (cdc.gov)
- Breathing in stray asbestos fibers after they have been disturbed can lead to several fatal diseases, including asbestos-caused lung cancer, mesothelioma, and asbestosis. (sokolovelaw.com)
- It is fatal and typically causes death by heart disease around the age of fourteen. (americanpregnancy.org)
Lung1
- Asbestos can also cause lung cancer, and a deadly disease known as asbestosis. (sokolovelaw.com)
Antibodies2
- In Graves' disease, abnormal antibodies that imitate TSH are released through a malfunction in the body's immune system. (easydna.in)
- In Graves' disease, your immune system attacks your thyroid gland with antibodies, resulting in the release of too much hormone. (healthline.com)
Dementia1
- A class of drugs used to treat mild to moderate dementia in Parkinson's disease. (michaeljfox.org)
Rare inherited1
- A genetic mutation in this protein is the basis for a rare inherited form of Parkinson's disease. (michaeljfox.org)
Testing12
- Genetic testing was performed on all patients with diagnosed CJD. (cdc.gov)
- And that's testing for diseases. (jt.org)
- The life insurance industry in Canada recently announced new measures it will take to protect clients from discrimination in regards to genetic testing. (lsminsurance.ca)
- Anyone applying for coverage up to $250,000 will not be required to provide genetic testing information or results from previous tests. (lsminsurance.ca)
- Companies may ask individuals for genetic testing information for greater insurance amounts, but not if the tests were taken for medical purposes or if the outcome is unknown. (lsminsurance.ca)
- Family members of the applicant will not be required to undergo genetic testing. (lsminsurance.ca)
- One area that has grown significantly in recent years is genetic testing. (lsminsurance.ca)
- According to MedCan , approximately two-thirds of people who take part in genetic testing make a change in their diet and level of physical activity. (lsminsurance.ca)
- One hot-button topic that has received a lot of attention recently is life insurance and genetic testing. (lsminsurance.ca)
- An amendment to the Canada Labour Code preventing employers from demanding genetic testing or the disclosure of results from employees. (lsminsurance.ca)
- The side in favour of the bill, like the Canadian Coalition for Genetic Fairness , fears that being forced to disclose genetic testing and the results, will discourage people from being tested. (lsminsurance.ca)
- The use of genetic testing is becoming increasingly routine in patient care. (cdc.gov)
Researchers1
- Researchers investigated the effect of daily consumption of mixed nuts on cardiovascular disease biomarkers in overweight and obese adults. (news-medical.net)
Typically2
- HoFH is a rare genetic condition that, if untreated, can cause extremely High cholesterol levels, typically between 400 mg/dL and 1,000 mg/dL. (health.am)
- CD is typically a disease of ileum and colon, but can also affect other areas of the digestive tract[ 4 ], forms granulomas and involves the whole intestinal wall, while UC is an ulcerative and inflammatory disease usually limited to superficial layers (mucosa, superficial part of the submucosa) of the colon[ 5 ]. (wjgnet.com)
Graves2
- Graves' disease or sometimes called exophthalmic goitre stimulates the thyroid to produce too much thyroid hormone (Hyperthyroidism). (easydna.in)
- No single gene triggers Graves' disease. (easydna.in)
Immune1
- Regular exercise also benefits the immune system, reducing inflammatory markers like CRP, IL-6 and TNF, which are known to be associated with chronic disease. (forbes.com)
Results3
- A genetic predisposition results from specific genetic variations that are often inherited from a parent. (medlineplus.gov)
- What we wanted to do is ensure the vast majority of Canadians would be able to buy life insurance and not need to worry about this issue of genetic test results," Frank Swedlove, president and CEO of the Canadian Life and Health Insurance Association, said in an interview. (lsminsurance.ca)
- The creation of a Genetic Non-Discrimination Act that would prohibit the disclosure of genetic test results as a condition of providing goods and services, specifically health and life insurance. (lsminsurance.ca)
Specific3
- Specific, measurable physical traits used to determine or indicate the effects or progress of a disease or condition. (michaeljfox.org)
- Research investigates the connection between circadian rhythms and specific microbial patterns in various disease contexts, emphasizing the need for further studies. (news-medical.net)
- Many of the signs are non-specific or are seen in other common dog diseases so can be mistaken for other issues. (dogsnaturallymagazine.com)
Test4
- We're gonna take it out, test it for diseases, then that thing is going right in the trash. (jt.org)
- Robinsons', we're gonna take it out, test it for diseases. (jt.org)
- We take it out, test it for diseases, and after that, who knows what we're gonna do? (jt.org)
- In this case, the rose is we will test it for diseases. (jt.org)
Occur1
- Progeria does not occur because the mother or father has a genetic predisposition for the disorder. (americanpregnancy.org)
Type2
- The major type of human prion disease is Creutzfeldt-Jakob disease (CJD), and several countries have reported increasing trends in CJD cases and incidence ( 4 ). (cdc.gov)
- A genetic condition can be considered a type of disability. (lsminsurance.ca)
Characteristics2
- Normal animals modified mechanically, genetically or chemically, used to demonstrate all or part of the characteristics of a disease. (michaeljfox.org)
- An amendment to the Canadian Human Rights Act prohibiting discrimination on the base of genetic characteristics. (lsminsurance.ca)